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Scope of the Series
The major pathologies which dentists encounter in clinical practice include dental 
caries and periodontal diseases. Diagnosis and treatment of these pathologies is 
essential because when untreated, abscess could occur and it can even lead to the 
extraction of the tooth. Extracted teeth can be replaced with implants. Dentists and 
patients are nowadays more familiar with dental implant treatments. As a result,  
advanced diagnostic tools which aid in pre-operative treatment planning (cone-
beam computed tomography, computer aided implant planning etc..), new implant 
designs improving the success of osteointegration, new materials, and techniques 
are introduced in the dental market.
Conditions which dentists frequently encounter in their clinical practice are tem-
poromandibular joint (TMJ) disorders. These disorders include degenerative mus-
culoskeletal conditions associated with morphological and functional deformities. 
Accurate diagnosis is important for proper management of TMJ pathologies. With 
the advance in technology, new materials, techniques and equipment are introduced 
in the dental practice. New diagnostic aids in dental caries detection, cone-beam 
computed tomographic imaging, soft and hard tissue lasers, advances in oral and 
maxillofacial surgery procedures, uses of ultrasound, CAD/CAM, nanotechnology, 
plasma rich protein (PRP) and dental implantology are some of them. There will be 
even more new applications in dentistry in the future.
This book series includes topics related to dental caries, dentomaxillofacial imaging, 
new trends in oral implantology, new approaches in oral and maxillofacial surgery, 
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Periodontal diseases are a group of chronic immune-inflammatory diseases that, 
according to their severity, may induce different levels of periodontal destruction. 
Such diseases could range from mild gingivitis to severe periodontitis. Although
there is similarity in the nature of the periodontal diseases in general, each disease
has special characteristics. These characters could differ if the disease is solitary or
it could be a reflection of a systemic disease.
The goal of this book is to clarify the main structure of periodontal diagnosis and 
discuss the most recent modalities in non-surgical adjunctive therapeutic aids.
Unfortunately, in 2019, periodontal diseases became some of the most common
diseases that affect human beings all over the world. Periodontal diseases reported 
relatively higher prevalence in developing countries, especially in children due
to nutrition deficiency, hygiene problems, awareness, low educational and social 
levels, limited financial aids, and limited diagnostic privilege.
The multifactorial nature of the disease makes the early identification and diagnosis
more difficult. Therefore, it is clear that there is no single diagnostic aid that can
provide full clinical assessment of the different periodontal conditions.
The higher prevalence of periodontal diseases is mainly due to the delay of the
patients asking for dental examination and treatment at the onset stage of the
disease. Unfortunately, patients usually ask for diagnosis and treatment when the
disease reaches an advanced stage. Late diagnosis could lead to loss of the affected 
teeth as well as severe damage to the remaining structures. Nowadays, there is great
improvement in the diagnostic aids that could facilitate the early discovery of such
diseases.
The main requirements that are needed for an ideal diagnostic aid is to be easy to
use, informative, non-invasive, cost effective, and accepted by patients. Nowadays, 
biomarkers, radiographic evaluations, and genetic analysis are the main informative
and most recent diagnostic aids in the periodontal field.
In the last few decades, biomarkers have developed great potential to be used for
diagnosis of periodontal diseases. The main function of the biomarker is to indicate
the presence and severity of the disease and report the responses of the periodontal 
tissues to any therapeutic interventions.
The great evolution in the radiographic aids makes the early monitoring of the
changes of periodontal hard structure easier. There has been development of a
wide spectrum of radiographic techniques such as the subtractive and topographic
technique.
Lately, the literature has recorded several non-surgical techniques that could act as
adjunctive modalities to treat mild to moderate conditions and serve as a treatment
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aid in severe conditions. LASER therapy, photodynamic therapy, oral mesotherapy, 
and locally delivered antibiotics and anti-inflammatories are all examples of this.
Hopefully, this book will serve as a guide and an overview for researchers and 
practitioners who are interested in the periodontal diagnosis and non-surgical 
therapeutic modalities. I really hope this book could inspire researchers for future 
research and innovative ideas. The book consists of six chapters, with each chapter 
focussing on a certain point of the diagnostic aids. All chapters attempt to cover the 
topic in a systematic way starting with background information on the subject, with 
a detailed description for the advantages, limitations, types, methods to apply the 
technique, and points of future research.
Chapter 1 describes an overview of the pathogenesis of periodontal diseases and 
the contributing factors in periodontal destruction. Chapter 2 describes in-depth 
the role of biomarkers in diagnosis of periodontal diseases. The advantages and 
limitations of the various biomarkers will be discussed in order to recognize new 
points of research. In Chapter 3, the genetic biomarkers are discussed to clarify the 
role of the diagnostic aids in specifying the association between the periodontal dis-
ease and genetic disorders such as gene polymorphism. Chapter 4 gives a detailed 
description about the role of the radiographic revolution as a diagnostic aid for 
periodontal diseases. In Chapter 5, an overview of one of the most recent non-sur-
gical adjunctive modalities, oral mesotherapy, is presented. This technique provides 
promising results in the management of periodontal diseases and is considered as a 
virgin point for future research.
Nermin Mohammed Ahmed Yussif
Periodontology Department - Faculty of Dentistry,
MSA University,
Giza, Egypt
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Abstract
Inflammation is a physiological response of the innate immune system against 
several endogenous or exogenous stimuli. Inflammation begins with an acute pat-
tern; however, it can become chronic by activating the adaptive immune response 
through cellular and noncellular mechanisms. The main etiologic factor of periodon-
tal disease is bacteria which substantially harbor the human oral cavity. The most 
common periodontal diseases are gingivitis and periodontitis, whose main charac-
teristic is inflammation. The knowledge of how immune mechanisms and inflam-
matory responses are regulated is fundamental to understanding the pathogenesis of 
periodontal disease. The purpose of this chapter is to show the current panorama of 
the immunological mechanisms involved in the pathogenesis of periodontal disease.
Keywords: periodontal tissues, biofilm, inflammatory response,  
innate and adaptive immunity, periodontitis
1. Introduction
Periodontitis is a globally widespread pathology of the human oral cavity. 
Approximately 10% of the global adult population is highly vulnerable to severe 
periodontitis, and 10–15% appears to be completely resistant to it, while the 
remainder varies between these two situations [1]. Periodontitis is a major public 
health problem due to its high prevalence, as well as because it may lead to tooth 
loss and disability, negatively affect chewing function and aesthetics, be a source of 
social inequality, and impair the quality of life. Periodontitis accounts for a substan-
tial proportion of edentulism and masticatory dysfunction, results in significant 
dental care costs, and has a plausible negative impact on general health [2].
2. Periodontal support tissues
The periodontium is a complex of tissues with blood vessels, nerves, and 
bundles of fibers, which provide nutrition and sensibility, supporting and invest-
ing the tooth. The periodontium has the potential for regeneration and remodel-
ing throughout life, which allows the primary dentition to be transient and to be 
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replaced by the permanent dentition [3, 4]. It is important to understand that each 
of the periodontal tissues has a very specialized structure and that these structural 
characteristics directly define the function. In fact, the proper functioning of the 
periodontium is only achieved through the structural integrity and interaction 
between its components [4].
The periodontium is one of the morphofunctional components of the stomato-
gnathic system, and its “design” not only responds to intrinsic functions related to 
nutrition or the subjection of the tooth but also to functions integrated within the 
physiology of the stomatognathic system [5]. The main function of the periodon-
tium is to join the tooth to the bone tissue and maintain integrity on the surface 
of the masticatory mucosa of the oral cavity [6]. The periodontium includes four 
tissues located near the teeth: (1) the alveolar bone (AB), (2) root cementum (CR), 
(3) periodontal ligament (PL), and (4) gingiva (G) (e.g., Figure 1a) [4, 7, 8].
2.1 Alveolar bone
The alveolar bone, together with the root cementum and the periodontal 
ligament, constitutes the tooth insertion apparatus, whose main function is to 
distribute the forces generated by chewing and other contacts [6]. The maxilla and 
mandible of the adult human can be subdivided into two parts: (a) the alveolar 
process that involves in housing the roots of the erupted teeth and (b) the basal 
body that does not involve in housing the roots [8].
Figure 1. 
Periodontal tissues. (a) Tissues that support the tooth include the alveolar bone (AB), root cementum (RC), 
periodontal ligament (PL), and gingiva (G). (b) Forms of cementum: acellular afibrillar cementum (AAC), 
acellular extrinsic fibers cementum (AEFC), cellular mixed stratified cementum (CMSC), and cellular 
intrinsic fibers cementum (CIFC). (c) Bundles of collagen fibers: crestal alveolar fibers (CAF), horizontal 
fibers (HF), oblique fibers (OF), and apical fibers (AF). (d) Parts of the gingiva: free gingiva (FG), 
interdental gingiva (IG), and attached gingiva (AG).
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The alveolar process is the bone of the jaws that contain the sockets (alveoli) 
of the teeth. It consists of outer cortical plates (buccal, lingual, and palatal) of the 
compact bone, a central spongiosa, and bone lining the alveolus (alveolar bone) 
[4]. The alveolar process is dependent on the teeth as they develop and remodel 
with their formation and eruption. Therefore, the shape, location, and function 
of the teeth determine its morphology [8]. The periodontal ligament contains 
progenitor cells that can differentiate into osteoblasts for the maintenance and 
repair of the alveolar bone. However, in the absence of the tooth, it is lost. These 
characteristics suggest that the regulatory mechanisms are important for the 
alveolar bone, so there is an interdependence of the periodontal tissues, which 
work together as a unit [4].
2.2 Root cementum
The root cementum is an avascular mineralized connective tissue covering 
the entire root surface, forming the interface between the root dentine and the 
periodontal ligament [6, 7]. In addition, the root cementum plays important 
roles in nourishing the tooth as well as in stabilizing the tooth via the attachment 
to the periodontal ligament. This enables the tooth to maintain its relationship 
to adjacent and opposing teeth [3]. Unlike the bone, the root cementum does 
not contain blood or lymphatic vessels, lacks innervation, and does not undergo 
remodeling or physiological resorption, but it is characterized by the fact that 
continues to be deposited throughout life [6]. The composition of cementum 
contains about 50% mineral (substituted apatite) and 50% organic matrix. Type 
I collagen is the predominant organic component, constituting up to 90% of the 
organic matrix. Other collagens associated with cementum include type I, III, V, 
VI, XII, and XIV [4].
Cementum performs different functions: it fixes the main fibers of the peri-
odontal ligament to the root and contributes in the repair process when the root 
surface has been damaged [6]. Cementum has been classified as cellular and acel-
lular cementum depending on the presence and absence of cementocytes, further 
grouped into intrinsic and extrinsic fiber cementum depending on the presence of 
collagen fibers formed by cementoblasts or by fibroblasts, respectively [8]. There 
are different forms of cementum (e.g., Figure 1b): (1) acellular afibrillar cementum 
(AAC), (2) acellular extrinsic fiber cementum (AEFC), (3) cellular mixed stratified 
cementum (CMSC), and (4) cellular intrinsic fibers cementum (CIFC) [4, 6].
2.3 Periodontal ligament
The periodontal ligament is the soft and specialized connective tissue situated 
between the cementum covering the root of the tooth and the bone forming the 
socket wall (alveolodental ligament) [4]. The periodontal ligament consists of cells 
and an extracellular compartment comprising collagenous and noncollagenous 
matrix constituents. The cells include osteoblasts and osteoclasts, fibroblasts, 
epithelial cell rests of Malassez, monocytes and macrophages, undifferentiated 
mesenchymal cells, and cementoblasts and odontoclasts. The extracellular com-
partment consists mainly of well-defined collagen fiber bundles embedded in an 
amorphous background material, known as ground substance [4, 8]. These bundles 
of collagen fibers can be classified into the following groups, according to their 
disposition (e.g., Figure 1c): crestal alveolar fibers (CAF), horizontal fibers (HF), 
oblique fibers (OF), and apical fibers (AF) [6].
The main function of the periodontal ligament is to support the teeth in their 
sockets and at the same time allow them to withstand the considerable forces of 
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mastication. In addition, the periodontal ligament has the capacity to act as a sensory 
receptor necessary for the proper positioning of the jaws during mastication, and, very 
importantly, it is a cell reservoir for tissue homeostasis, regeneration, and repair [4].
2.4 Gingiva
Gingiva is a portion of the oral mucosa covering the tooth-carrying part of the 
alveolar bone and the cervical neck of the tooth. Three parts of the gingiva can 
be distinguished (e.g., Figure 1d): (1) free gingiva (FG), (2) interdental gingiva 
(IG), and (3) attached or inserted gingiva (AG) [6]. Histologically, the epithelial 
component of the gingiva shows regional morphological variations that reflect the 
adaptation of the tissue to the tooth and alveolar bone. These include the epithelium 
that covers a connective tissue, chorion, or lamina propria. A keratinized stratified 
squamous epithelium protects the lamina propria of the gingiva on its masticatory 
surfaces and a nonkeratinized epithelium protects the lamina propria on its crevicu-
lar and junctional surfaces [6, 9]. The junctional epithelium plays a crucial role since 
it essentially seals off periodontal tissues from the oral environment. Its integrity is 
thus essential for maintaining a healthy periodontium. Periodontal disease sets in 
when the structure of the junctional epithelium starts to fail, an excellent example 
of how structure determines function [4].
During pathological conditions, such as inflammation, the periodontal con-
nective tissues, including the gingiva, undergo many changes. Clinically detected 
gingival overgrowth is one of the alterations that occurs in chronic periodontitis. 
It is caused by a variety of etiological factors and is exacerbated by local bacterial 
biofilm accumulation, because the periodontopathogen products act on the gingival 
tissues activating cellular events that induce the alteration of connective tissue 
homeostasis and the destruction of the alveolar bone [9]. Likewise, junctional 
epithelial cells differ considerably from those of the gingival epithelium. There are 
polymorphonuclear leukocytes and monocytes that pass from the subepithelial 
connective tissue through the junctional epithelium and into the gingival sulcus. 
The mononuclear cells, together with molecules they secrete and others originating 
from junctional epithelial cells, blood and tissue fluid, represent the first line of 
defense in the control of the perpetual microbial challenge [4].
3. Periodontal pathogenesis
Periodontitis is a chronic multifactorial disease characterized by an inflam-
mation of the periodontal tissue mediated by the host, which is associated with 
dysbiotic plaque biofilms, resulting in the progressive destruction of the tooth-
supporting apparatus and loss of periodontal attachment [1, 10]. The bacterial 
biofilm formation initiates gingival inflammation; however, periodontitis initiation 
and progression depend on dysbiotic ecological changes in the microbiome in 
response to nutrients from gingival inflammatory and tissue breakdown products 
and anti-bacterial mechanisms that attempt to contain the microbial challenge with 
in the gingival sulcus area once inflammation has initiated. This leads to the activa-
tion of several key molecular pathways, which ultimately activate host-derived 
proteinases that enable loss of marginal periodontal ligament fibers, apical migra-
tion of the junctional epithelium, and allows apical spread of the bacterial biofilm 
along the root surface [1]. Therefore, the primary features of periodontitis include 
the loss of periodontal tissue support, manifested through clinical attachment loss 
and radiographically assessed alveolar bone loss, presence of periodontal pocketing, 
and gingival bleeding [10].
7
Pathogenesis of Periodontal Disease
DOI: http://dx.doi.org/10.5772/intechopen.86548
3.1 Periodontal histopathology
The development of gingivitis and periodontitis can be divided into a series 
of stages: initial, early, established, and advanced lesions (e.g., Figure 2) [11, 12]. 
The initial lesion begins 2–4 days after the accumulation of the microbial plaque. 
During the initial lesion, an acute exudative vasculitis in the plexus of the venules 
lateral to the junctional epithelium, migration of polymorphonuclear (PMN) cells 
through the junctional epithelium into the gingival sulcus, co-exudation of fluid 
from the sulcus, and the loss of perivascular collagen were observed. The early 
injury develops within 4–10 days. This lesion is characterized by a dense infiltrate of 
T lymphocytes and other mononuclear cells, as well as by the pathological alteration 
of the fibroblasts [6, 11–13].
Subsequently, the established lesion develops within 2–3 weeks. This lesion is 
dominated by activated B cells (plasma cells) and accompanied by further loss 
of the marginal gingival connective tissue matrix, but no bone loss is yet detect-
able. Several PMN continue to migrate through the junctional epithelium, and the 
gingival pocket is gradually established. Finally, in the advanced lesion, plasma 
cells continue to predominate as the architecture of the gingival tissue is disturbed, 
together with the destruction of the alveolar bone and periodontal ligament. It is 
characterized by a conversion of junctional epithelium to the pocket epithelium, 
formation of denser inflammatory infiltrate composed of plasma cells and mac-
rophages, loss of collagen attachment to the root surface, and resorption of the 
alveolar bone [6, 11–13].
3.2 Immune responses in the pathogenesis of periodontal disease
In normal health conditions, periodontal tissues are capable of coping with 
the presence of bacteria through several mechanisms of the host immune system 
(e.g., Figure 3) [14]. However, when the balance between the infection control 
mechanisms and the subgingival biofilm is lost [15], which includes Porphyromonas 
Figure 2. 
Histopathological lesions of periodontal pathogenesis. Initial, early, established, and advanced lesions of the 
development of gingivitis and periodontitis.
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gingivalis, Aggregatibacter actinomycetemcomitans, Tannerella forsythia, and Treponema 
denticola [16], innate, inflammatory, and adaptive reactions are triggered. These 
processes result in the destruction of the tissues that surround and support the teeth, 
and eventually in the loss of tissues, bones and finally, of the teeth [17].
3.2.1 Innate immune response in periodontal disease
The most important characteristic of periodontitis is the inflammatory 
reabsorption of the tooth-supporting alveolar bone due to the uncontrolled host 
immune response against periodontal infection, since the destructive events, 
which lead to the irreversible phenotype of periodontal disease, are the result of 
the persistence of a chronic and exacerbated inflammatory immune response [18]. 
Inflammation is a process of the innate immune system activation, in response to 
exogenous and endogenous factors, such as infection by microorganisms, tissue 
stress, and injuries. Inflammation is a protective response, characterized by its 
cardinal signs, such as redness, swelling, heat, pain, and disrupted function [19]. 
The inflammatory response consists of four main components: (1) endogenous or 
exogenous factors, such as molecular patterns associated with pathogens (PAMP) 
and damage (DAMP), which are derived from bacteria, viruses, fungi, parasites, 
and cell damage, as well as toxic cellular components or any other harmful condi-
tion; (2) cellular receptors that recognize these molecular patterns (PRR), for 
example, Toll-like receptors (TLR); (3) proinflammatory mediators, such as cyto-
kines, chemokines, the complement system, etc.; and (4) target cells and tissues, 
where these proinflammatory mediators act [20, 21]. The inflammatory response 
is mainly characterized by four successive phases: (1) silent phase, where the cells 
synthesize and release the first proinflammatory mediators; (2) vascular phase, 
characterized by an increase in vascular permeability and dilatation; (3) cellular 
Figure 3. 
Innate and adaptive immune response during periodontal disease (description in the text).
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phase, characterized by the infiltration of inflammatory cells at the site of injury; 
and (4) the resolution of the inflammatory response [22].
The inflammatory immune response is triggered by the interaction of resident 
cells with the bacterial biofilm attached to the tooth surface. Bacterial biofilm 
attaches to the tooth surface, making it impossible for the immune system to 
eradicate the infecting microorganisms efficiently, perpetuating the insult to the 
periodontal tissues [18]. The junctional epithelium is the first periodontal structure 
to face the bacterial challenge [23]. Bacteria are capable to cross the junctional 
epithelium and pass to the gingival conjunctive tissue, where they stimulate the 
gingival epithelial cells and fibroblasts to trigger the initial inflammatory responses 
[24]. These resident periodontal cells detect bacterial PAMP, such as lipopolysac-
charide (LPS) [25], which binds to the Toll-like receptors (TLR4/2), triggering 
the recruitment of several protein kinases in the cytoplasmic end of the receptors, 
ultimately causing the activation of proinflammatory transcription factors, such as 
nuclear factor kappa B (NFκB) and activator protein 1 (AP-1) [26], which induces 
the synthesis and release of mediators to trigger the inflammatory response. 
Likewise, the gingival fibroblasts and the periodontal ligament are responsible for 
the destruction and disorganization of the fibrous component of the extracellular 
matrix of the periodontal tissue by increasing the local production and the activity 
of the matrix metalloproteinases (MMPs) [27, 28].
The periodontal lesion is initiated as acute inflammation characterized by 
increased numbers of neutrophils migrating into the gingival crevice through the 
junctional epithelium, which have the de novo biosynthetic capacity for chemo-
kines and cytokines with proinflammatory, anti-inflammatory, or immunoregula-
tory properties. Neutrophils, through the release of chemokines, can induce the 
recruitment of interleukin-17-producing CD4-positive T-helper 17 cells to sites of 
infection or inflammation. In addition, they can promote the survival, prolifera-
tion, and development of B cells into antibody-secreting plasma cells. Likewise, it 
was shown that activated neutrophils express membrane-bound receptor activator 
of nuclear factor kappa Β ligand (RANKL), a key osteoclastogenic cytokine and, 
thereby able of inducing osteoclastic bone resorption [29]. These recent concepts 
suggest that neutrophils could contribute to periodontitis not only by initiating the 
lesion but also by participating in its progression, by recruiting T-helper 17 cells 
or promoting the accumulation of B cells and plasma cells in the established and 
advanced lesions.
Macrophages are an important source of proinflammatory and potentially 
destructive molecules for tissues, such as interleukin-1 (IL-1), tumor necrosis factor 
alpha (TNF-α), MMP, and prostaglandin E2 [30], which play an important role and 
are elevated in the gingival tissue and in the gingival crevicular fluid of patients 
with chronic periodontitis [28]. Therefore, studies have shown a direct correlation 
of macrophage infiltration with the severity of periodontal disease [31], contribut-
ing greatly to the intensification of the degradation of the collagen matrix in the 
connective periodontal tissue [32, 33]. These macrophages may undergo a classical 
(M1) or alternative (M2) activation. M1 macrophages are induced by microbial 
agents (e.g., LPS) or by Th1 cytokines and show high phagocytic capacity and an 
increased expression of proinflammatory cytokines, costimulatory, and antimi-
crobial molecules. In contrast, M2 macrophages are induced by Th2 cytokines 
and secrete high levels of IL-10 and transforming growth factor beta 1 (TGF-β1). 
Therefore, they have immunoregulatory properties and promote cell proliferation 
and tissue regeneration [29, 34]. In periodontal inflammation models, macrophages 
share properties of both M1 and M2. However, M1 macrophages show a predomi-
nance over M2 macrophages, suggesting that M1 macrophages probably represent a 
subset associated with periodontitis [35–37].
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3.2.2 Adaptive immune response in periodontal disease
When the inflammatory response becomes chronic, the lymphocytes of the 
adaptive immune system invade the periodontal tissues releasing inflammatory and 
immune molecular mediators, which alter the balance of bone metabolism, marking 
the transition from gingivitis to periodontitis [29]. The activation of lymphocytes 
requires two types of signals: a signal induced by the antigen receptor itself when 
recognizing its related antigen and a costimulatory signal by professional antigen-
presenting cells (APCs) [22]. In gingivitis, the predominant APCs are CD14+ and 
CD83+ dendritic cells. While in the periodontitis, the predominant APCs are CD19+ 
and CD83+ B lymphocytes [38]. Therefore, the activation of adaptive immunity 
has a great influence on the bone loss in periodontitis, associated with B and T 
lymphocytes, since several studies have shown that these cells are the main cellular 
sources of activator of the κB ligand receptor of the nuclear factor (RANKL) during 
periodontal inflammation [39].
RANKL is a cytokine member of the TNF family that can be bound or secreted to 
the membrane and stimulates the differentiation of osteoclasts, cell fusion, and acti-
vation that leads to bone resorption [40, 41]. Osteoblasts and stromal cells of the bone 
marrow predominantly express RANKL bound to the membrane, which induces 
osteoclastogenesis through cell contact with osteoclast precursors. Likewise, activated 
T and B cells produce both the membrane-bound and soluble RANKL forms. Soluble 
RANKL can induce osteoclastogenesis independently of direct contact between 
infiltrating lymphocytes and osteoclast precursors on the bone surface. However, 17 
T-helper cells expressing RANKL, but not T-helper 1 cells, activate osteoclasts also 
by direct cell-cell contact [42]. In the alveolar bone, the RANKL/OPG/RANK system 
controls the balance of the bone metabolism [43]. RANKL is the osteoclasts activator 
and the molecular signal directly responsible for the bone resorption, which interacts 
with its associated receptor RANK on the surface of osteoclast and osteoclast precur-
sors, which triggers its recruitment on the bone surface and cell fusion and activation 
[44]. Osteoprotegerin (OPG) is a soluble protein that has the ability to block the 
biological functions of RANKL by competitive inhibition [45]. In periodontitis, the 
increase in RANKL/OPG promotes the recruitment of osteoclast precursors, their 
fusion, and subsequent activation, leading to bone resorption [46].
On the other hand, Th1 lymphocytes have a fundamental role in the establish-
ment and progression of periodontitis, through the increase of IFN-γ levels [18]. 
Studies have shown that mice IFN-γ-deficient showed low levels of inflammatory 
cytokines and chemokines, as well as macrophages infiltrated in periodontal tissue, 
developing a less severe phenotype of alveolar bone destruction [47]. IL-1β and 
TNF-α are cytokines secreted by Th1 lymphocytes. TNF-α and IL-1β produce vaso-
dilation, stimulate the activation of endothelial cells to increase the recruitment of 
immune cells, increase the chemokines production in most cell types, participate in 
the activation of neutrophils, and stimulate secretion and tissue activation of MMPs, 
among other functions. Although neither IL-1β nor TNF-α is directly involved in the 
stimulation of bone resorption, they indirectly promote bone destruction by stimu-
lating sustained inflammation of the periodontal tissue [48]. Th2 lymphocytes are 
the main cellular source of IL-4, which promotes the change of class to the secretion 
of IgE in B cells and favors the alternative activation of macrophages in an IFN-γ-
independent pathway. These effector functions of the Th2 lymphocytes negatively 
regulate the inflammatory and Th1 lymphocyte responses, so that the polarization 
of a Th2-type immune response in periodontitis may represent a damaged adaptive 
immune response [18, 49]. Finally, RANKL can also be secreted by Th17 lympho-
cytes, which in cooperation with inflammatory cytokines derived from Th1 lympho-
cytes are capable to tilt bone metabolism favoring bone resorption [50].
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4. Conclusion
The main etiological factor of periodontal disease is the bacteria, which are 
capable of activating the innate immune response of the host inducing an inflam-
matory response. The evolution of this inflammatory response culminates in the 
destruction of periodontal tissues. For this reason, it is important to understand 
the different molecular and cellular mechanisms of the pathogenesis of periodontal 
disease, with the purpose of making an opportune diagnosis and appropriate treat-
ment and prognosis.
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Abstract
Periodontal disease is the most common oral condition of human population; 
if periodontitis is not treated in its initial stages, it can cause the loss of teeth. The 
diagnosis of periodontitis is based on clinical measurements. However, currently 
with the advancement of technology, other diagnostic and monitoring options are 
being search. In fact, different types of biomarkers have been evaluated where dif-
ferent biological fluids have been used as a source of the sample. We will try to sum-
marize existing biomarkers of different periodontitis stages and make a comparison 
of the periodontal biomarkers evaluated so far and their usefulness in diagnosis and 
monitoring of periodontitis.
Keywords: biomarkers, periodontitis, dentobacterial plaque, gingivitis
1. Introduction
Health in general is fundamental in humans, oral health plays an important role, 
and any alteration in it can influence the general welfare of individuals. Diseases of 
the oral cavity are very important due to its high incidence and prevalence accord-
ing to the World Health Organization [1].
Regarding the epidemiology of the disease, we can say that from 5 to 15% of the 
population of the United States suffers from severe periodontitis [2]. Data from the 
Department of Health of Mexico mention that approximately 8.8% of the Mexican 
population has chronic periodontitis. This is more common among subjects 35 years 
of age and older, where it is estimated that the frequency is 22% [3].
Periodontitis is a chronic inflammatory disease that compromises the integrity of the 
tissues that support the teeth, which include the gingiva, periodontal ligament, dental 
cement, and alveolar bone, and are collectively known as the periodontium [4, 5].
This disease is caused by specific microorganisms or groups of specific microor-
ganisms, which in the end produce a greater formation of probing depth, recession, 
or both. When these conditions remain, they cause the tissue to be destroyed and 
the tooth to be lost. This disturbs the mastication, phonation, and esthetics of the 
patient, which affect the quality of life [4].
The traditional treatment for periodontitis decreases the microbial presence by 
means of the mechanical interruption and the elimination of the bacterial layers 
that form in the surfaces of the teeth and adjacent soft tissues [2].
19
Chapter 2
Use of Biomarkers for the 
Diagnosis of Periodontitis
Javier González-Ramírez, Nicolás Serafín-Higuera,  
Marina Concepción Silva Mancilla,  
Gustavo Martínez-Coronilla, Jesús Famanía-Bustamante  
and Ana Laura López López
Abstract
Periodontal disease is the most common oral condition of human population; 
if periodontitis is not treated in its initial stages, it can cause the loss of teeth. The 
diagnosis of periodontitis is based on clinical measurements. However, currently 
with the advancement of technology, other diagnostic and monitoring options are 
being search. In fact, different types of biomarkers have been evaluated where dif-
ferent biological fluids have been used as a source of the sample. We will try to sum-
marize existing biomarkers of different periodontitis stages and make a comparison 
of the periodontal biomarkers evaluated so far and their usefulness in diagnosis and 
monitoring of periodontitis.
Keywords: biomarkers, periodontitis, dentobacterial plaque, gingivitis
1. Introduction
Health in general is fundamental in humans, oral health plays an important role, 
and any alteration in it can influence the general welfare of individuals. Diseases of 
the oral cavity are very important due to its high incidence and prevalence accord-
ing to the World Health Organization [1].
Regarding the epidemiology of the disease, we can say that from 5 to 15% of the 
population of the United States suffers from severe periodontitis [2]. Data from the 
Department of Health of Mexico mention that approximately 8.8% of the Mexican 
population has chronic periodontitis. This is more common among subjects 35 years 
of age and older, where it is estimated that the frequency is 22% [3].
Periodontitis is a chronic inflammatory disease that compromises the integrity of the 
tissues that support the teeth, which include the gingiva, periodontal ligament, dental 
cement, and alveolar bone, and are collectively known as the periodontium [4, 5].
This disease is caused by specific microorganisms or groups of specific microor-
ganisms, which in the end produce a greater formation of probing depth, recession, 
or both. When these conditions remain, they cause the tissue to be destroyed and 
the tooth to be lost. This disturbs the mastication, phonation, and esthetics of the 
patient, which affect the quality of life [4].
The traditional treatment for periodontitis decreases the microbial presence by 
means of the mechanical interruption and the elimination of the bacterial layers 
that form in the surfaces of the teeth and adjacent soft tissues [2].
Periodontal Disease - Diagnostic and Adjunctive Non-surgical Considerations
20
In the pathology of periodontitis, the clinical, radiographic, and histological 
characteristics of the gingival groove and pouch epithelium, the underlying connec-
tive tissue and the types of resident and infiltrating blood cells in the initial, early, 
established periodontal injury are known [6].
Currently, the diagnosis requires rapidity, sensitivity, and specificity since 
determining the stage in which the patient is located is fundamental for a good 
treatment; for this reason molecules are currently being sought that vary when 
the person is healthy and when the person has the disease. However, despite all the 
researches that exist regarding chronic inflammation, the diagnosis of periodontitis 
is based on clinical measurements; these not only show low sensitivity and specific-
ity as diagnostic tests but are also subjective and laborious. The objective of this 
chapter is to try to describe what a biomarker is, the types of biomarkers evaluated 
in periodontitis, the sources to obtain these biomarkers, and their usefulness.
2. Biomarkers
The definition of biomarkers as established by the National Institute of Health 
(NIH) is as follows: biomarkers are the biological, biochemical, anthropometric, 
physiological, etc. characteristics, which are objectively measurable, capable of 
identifying physiological or pathological processes, or a pharmacological response 
or a therapeutic intervention [7].
There are different types of biomarkers; the ideal biomarker must be specific, 
sensitive, predictive, rapid, economical, noninvasive, and stable in vivo and 
in vitro. Additionally, it must have enough preclinical and clinical relevance to 
modify decisions regarding the pathological process in which applies [7].
Before a biological marker is used in human health studies, its validation is 
fundamental; therefore, the selection and approval process requires careful con-
sideration of specificity and sensitivity, establishing accuracy, precision, quality 
assurance, analytical procedure, and interpretation of measurement data, which 
must be compared with other variables [8].
3. Biomarkers for the diagnosis of periodontitis
3.1 Importance of the different biomarkers used for the diagnosis of periodontitis
Because there are certain molecules, like trace elements, proteins (cytokines), 
and proteolytic enzymes, these have been considered as possible biomarkers of 
periodontal disease, we will try to discuss the relevance of these groups below.
3.1.1 Proteins (cytokines) involved in the inflammatory process of periodontitis
Inflammation has evolved as a protective response to an injury, is a primordial 
response that eliminates or neutralizes foreign organisms or materials, in general; the 
innate inflammatory response starts in minutes and, if all is well, resolves in a mat-
ter of hours. In contrast, chronic inflammation persists for weeks, months, or even 
years [9]. The inflammatory response that occurs in periodontal disease is mediated 
mainly by B and T lymphocytes, neutrophils, and monocytes/macrophages. These are 
activated to produce inflammatory mediators, including cytokines and chemokines 
[10]. Several pro-inflammatory cytokines including interleukins like IL-1, IL-6, IL-12, 
IL-17, IL-18, and IL-21; tumor necrosis factor alpha (TNFα); and interferon (IFN-γ) 
have been demonstrated to be involved in the pathogenesis of periodontitis [2].
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3.1.2 Metalloproteinases
There is significant evidence showing that collagenases, along with other matrix 
metalloproteinases, play an important role in periodontal tissue destruction. The 
main group of enzymes responsible for the collagen and other protein degradation 
in extracellular matrix (ECM) is matrix metalloproteinases (MMPs) [11]. Several 
works have shown that matrix metalloproteinases are upregulated in periodontal 
inflammation; transcription of matrix metalloproteinase genes is very low in 
healthy periodontal tissue. In periodontal disease, secretion of specific matrix 
metalloproteinases is stimulated or downregulated by various cytokines [12].
3.1.3 Calcium
The importance of calcium in the development of periodontal disease has been 
recognized since the 1980s [13]. In addition to this, a relationship has been found 
between people who suffer from periodontitis and who also have osteoporosis [14].
3.1.4 Alkaline phosphate
Alkaline phosphatase (ALP) is an intracellular enzyme. It is considered that 
when this enzyme increases in saliva, it can be determined that there is inflam-
mation and destruction of healthy tissues [15]. It is worth mentioning that other 
enzymes representative of tissue degradation are aspartate aminotransferase (AST), 
alanine aminotransferase (ALT), gamma-glutamyl transferase (GGT), alkaline 
phosphatase (ALP), and acid phosphatase (ACP) [16].
3.1.5 Phosphate
Phosphorus is an essential element and plays an important role in multiple biologi-
cal processes, due to the fact that maintaining physiological phosphate balance is of 
crucial biological importance for bone health [17]. Approximately 85% of phosphorus 
is in the bone, primarily compounded with calcium (Ca2+), the most abundant 
mineral in hydroxyapatite (HAP) crystals deposited on the collagen matrix [18].
The importance of phosphate in periodontal disease has been observed in 
X-linked hypophosphatemia (XLH); this disease is a rare skeletal genetic illness in 
which increased phosphate in the kidney produces hypophosphatemia and prevents 
normal mineralization of the bone and bone dentine. In a study of 2017, it was 
observed that the frequency and severity of periodontitis increased in adults with 
XLH and that the severity varied according to the treatment of hypophosphatemia. 
Patients who benefited from early and continuous phosphate supplementation 
during childhood had less loss of periodontal attachment than patients with late or 
incomplete supplementation [19].
3.1.6 pH
Although the pH of the oral cavity is between 5 and 9, it is also known to vary 
widely depending on several factors. There are studies that report that there is a sta-
tistically significant correlation between pH and periodontal pocket formation [20].
3.1.7 Oxidative stress
Periodontitis is an inflammatory disease of the supporting tissues of the teeth, it 
is defined as a complex infectious disease that results from the interaction of the 
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bacterial infection and the response of the host to the bacterial challenge, and the 
disease is modified by environmental factors, acquired risk factors, and genetic 
susceptibility [21]. In recent years, the inflammatory response has been  
associated with oxidative stress, specifically with reactive oxygen species since 
it is considered to play a central role in the progression of many inflammatory 
diseases [22].
Oxidative stress create multiple products in affected tissues, such as reactive 
oxygen species which are free radicals and other non-radical derivatives which 
are involved in normal cell metabolism [23], other metabolites can damage 
DNA such as 8-hydroxy2′-deoxyguanosine (8-OHdG) or 8-oxo-7,8-dihydro-2′-
deoxyguanosine (8-oxodG) which are two of the predominant forms of free radicals 
induced by oxidative lesions. In fact, 8-oxodG has been widely used as a biomarker 
for oxidative stress [24].
3.1.8 Telopeptide
Bone resorption is a basic physiological process that is central to the under-
standing of many key pathologies, with its most common oral manifestation seen 
as the alveolar bone destruction in periodontitis [25]. The osteoid matrix consists 
principally of collagen (90%), other smaller proteins, and proteoglycans. The 
main structural protein of the bone is type I collagen. Consequently, most available 
bone resorption markers are based on degradation products of type I collagen. 
According to Koizumi et al. [26], ICTP (telopeptide) is one of the best markers for 
clinical use.
3.1.9 miRNAs (microRNAs)
Nowadays, RNAs that do not code for protein have taken on great importance 
because, in addition to maintaining their importance in the determination of 
cellular phenotypes [27], now they are recognized as dynamic participants in the 
performance of cellular activities [28].
It has been mentioned and demonstrated that miRNAs are involved in bone 
metabolism, in fact, some studies have shown that they are associated with the activa-
tor of the nuclear factor receptor kappa-B ligand (RANKL) induced osteoclastogen-
esis. Within these miRNAs, miR-223 [29] was the first to associate with periodontal 
tissue, although other miRNAs such as miR-15a, miR-29b, miR-125a, miR-146a, 
miR148 / 148a, miR-223 and miR-92 have been identified more recently as important 
in periodontal health and have even been considered potential biomarkers [30].
3.1.10 Other markers of periodontal disease
Other biomarkers have been analyzed to determine periodontitis. One of these 
is chondroitin sulfate, which is a natural glycosaminoglycan (GAG) present in the 
extracellular matrix [31]; chondroitin sulfate is recognized for its immunomodula-
tory effects, such as the reduction of nuclear translocation NF-κB, the decrease in the 
production of pro-inflammatory cytokines interleukin-1β (IL-1β) and tumor necrosis 
factor alpha (TNF-α), and the decrease in expression and activity of nitric oxide 
synthase-2 (NOS-2) and cyclooxygenase-2 (COX-2) [32]. Another molecule that has 
been proposed as a possible biomarker is MUC-4. Mucins are high-molecular-weight 
glycoproteins, are involved in diverse biological functions, are members of trans-
membrane mucin family, and are expressed in airway epithelial cells and body fluids 
like saliva, tear film, ear fluid, and breast milk [33]. It has been reported that the 
production of MUC-4 could be regulated by inflammatory cytokines [34].
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3.2 Biomarkers determined in saliva
Saliva is a seromucous secretion, consisting of 99% water; however, saliva is also 
composed of glycoproteins, phosphate ions, bicarbonate, sodium, chlorine, fluo-
rine, calcium, and potassium and has a neutral pH [35], which forms a film of liquid 
consistency that covers the surface of the oral mucosa, with the purpose of lubricat-
ing it and keeping it moist among many other characteristics for the maintenance 
of oral health [36]. The composition of saliva varies from one place to another in the 
oral cavity of each individual [35]. If there are changes in its composition, there may 
be significant alterations in deterioration of the health of the host [37].
Due to the described characteristics of saliva, several authors have claimed 
that these salivary constituents may actually be useful indicators of both local and 
systemic disorders. These revelations have formed the basis of the field of saliva 
diagnosis and, therefore, have triggered research that culminated in the identifica-
tion of saliva-based biomarkers for disorders ranging from cancer to infectious dis-
eases [38]. In addition to the above, saliva has several advantages when compared to 
other sources for diagnosing diseases since saliva is easily collected and stored and 
ideal for early detection of disease as it contains specific soluble biological markers 
[39]. Saliva has been used to diagnose diseases as diverse as autoimmune disorders, 
cardiovascular diseases, diabetes, HIV, oral cancer, and oral diseases [40].
3.2.1 Proteins (cytokines) determined in saliva that could be used as biomarkers
In our review we observed that there are about 15 works that were dedicated to 
investigate the possible use of these proteins determined in saliva as biomarkers 
to determine periodontitis. We can say that of all the works, the majority focuses 
on comparing healthy groups with periodontitis; only three researches include the 
group of gingivitis, which indicates that this group should be used more for this 
type of studies. We need to remember that gingivitis is considered an intermediate 
stage that may or may not lead to periodontitis [41], and if the patient performs 
good dental hygiene in combination with the treatment, in general, progression to 
periodontitis can also be stopped [42].
On the other hand, the cytokine that has been most explored and that better 
results have given as biomarkers to detect in saliva is the cytokine IL-1β [43–48]; 
this must be due to the recognized importance of interleukin-1β, as an important 
mediator in the pathophysiology of periodontitis [49].
However, other cytokines such as IL-6 and IL-2 have also been explored [43, 44, 
48, 50]; IL-6 is recognized for playing a role as a pro-inflammatory cytokine acting 
on bone resorption in the presence of infections [51]. Regarding IL-2, a study that 
investigated cytokine profiles at different stages of the development of periodontitis 
found that levels of mRNA for IL-2 were significantly associated with the phase of 
resolution of the disease [52]. This agrees with reports that IL-2 has been implicated 
in the stimulation of osteoclasts [53].
Regarding MCP-1, Gupta et al. [54] conducted a study in 45 patients with an 
average age of 43 years for healthy patients and 41 for patients with periodontitis, 
with results similar to Nisha et al. [55]. In both studies it was found that the levels 
of MCP-1 in saliva can be a good biomarker for the development of periodontal 
disease. One difference between the studies is that Nisha’s work included a group of 
patients with gingivitis, while Gupta’s study does not include it.
Regarding the possibility of using prostaglandin E2 (PGE2) as biomarkers in 
saliva to diagnose gingivitis, Syndergaard et al. [56] conducted a study with 80 
participants, 40 without gingivitis and 40 with gingivitis, and found that the levels 
of PGE2 in the group with gingivitis were significantly higher compared with the 
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3.2 Biomarkers determined in saliva
Saliva is a seromucous secretion, consisting of 99% water; however, saliva is also 
composed of glycoproteins, phosphate ions, bicarbonate, sodium, chlorine, fluo-
rine, calcium, and potassium and has a neutral pH [35], which forms a film of liquid 
consistency that covers the surface of the oral mucosa, with the purpose of lubricat-
ing it and keeping it moist among many other characteristics for the maintenance 
of oral health [36]. The composition of saliva varies from one place to another in the 
oral cavity of each individual [35]. If there are changes in its composition, there may 
be significant alterations in deterioration of the health of the host [37].
Due to the described characteristics of saliva, several authors have claimed 
that these salivary constituents may actually be useful indicators of both local and 
systemic disorders. These revelations have formed the basis of the field of saliva 
diagnosis and, therefore, have triggered research that culminated in the identifica-
tion of saliva-based biomarkers for disorders ranging from cancer to infectious dis-
eases [38]. In addition to the above, saliva has several advantages when compared to 
other sources for diagnosing diseases since saliva is easily collected and stored and 
ideal for early detection of disease as it contains specific soluble biological markers 
[39]. Saliva has been used to diagnose diseases as diverse as autoimmune disorders, 
cardiovascular diseases, diabetes, HIV, oral cancer, and oral diseases [40].
3.2.1 Proteins (cytokines) determined in saliva that could be used as biomarkers
In our review we observed that there are about 15 works that were dedicated to 
investigate the possible use of these proteins determined in saliva as biomarkers 
to determine periodontitis. We can say that of all the works, the majority focuses 
on comparing healthy groups with periodontitis; only three researches include the 
group of gingivitis, which indicates that this group should be used more for this 
type of studies. We need to remember that gingivitis is considered an intermediate 
stage that may or may not lead to periodontitis [41], and if the patient performs 
good dental hygiene in combination with the treatment, in general, progression to 
periodontitis can also be stopped [42].
On the other hand, the cytokine that has been most explored and that better 
results have given as biomarkers to detect in saliva is the cytokine IL-1β [43–48]; 
this must be due to the recognized importance of interleukin-1β, as an important 
mediator in the pathophysiology of periodontitis [49].
However, other cytokines such as IL-6 and IL-2 have also been explored [43, 44, 
48, 50]; IL-6 is recognized for playing a role as a pro-inflammatory cytokine acting 
on bone resorption in the presence of infections [51]. Regarding IL-2, a study that 
investigated cytokine profiles at different stages of the development of periodontitis 
found that levels of mRNA for IL-2 were significantly associated with the phase of 
resolution of the disease [52]. This agrees with reports that IL-2 has been implicated 
in the stimulation of osteoclasts [53].
Regarding MCP-1, Gupta et al. [54] conducted a study in 45 patients with an 
average age of 43 years for healthy patients and 41 for patients with periodontitis, 
with results similar to Nisha et al. [55]. In both studies it was found that the levels 
of MCP-1 in saliva can be a good biomarker for the development of periodontal 
disease. One difference between the studies is that Nisha’s work included a group of 
patients with gingivitis, while Gupta’s study does not include it.
Regarding the possibility of using prostaglandin E2 (PGE2) as biomarkers in 
saliva to diagnose gingivitis, Syndergaard et al. [56] conducted a study with 80 
participants, 40 without gingivitis and 40 with gingivitis, and found that the levels 
of PGE2 in the group with gingivitis were significantly higher compared with the 
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control group. This study reported that PGE2 remained high after prophylaxis. As 
for other studies conducted with the purpose of comparing the concentrations of 
PGE2, Sanchez et al. [82] conducted a study in which the population was 74 adult 
subjects who were grouped according to the progress of the periodontal disease in 
mild, moderate, and severe; the conclusion was that the levels of PGE2 increase as 
the severity of the periodontal disease progressed. In addition a high sensitivity and 
specificity were reported.
When TNF-α is evaluated as a possible biomarker for the diagnosis of periodon-
titis, we found that there are discrepancies since in some studies, such as Eivazi 
et al. [57] who conducted a study with one healthy group and another with chronic 
periodontitis which reported that before and after starting treatment, the concen-
trations of TNF-α in saliva were higher in the healthy group than in the periodon-
titis group. In contrary to the results reported by Yue et al. [48], they found that 
TNF-α concentrations were higher in the saliva of patients with advanced periodon-
titis than in the saliva of healthy subjects. Yue’s study is supported by studies that 
investigate the loss of the alveolar bone since the concentration of TNF-α in subjects 
with alveolar resorption is low [58].
Yue et al. [48] found that in the saliva of patients with aggressive periodontitis 
(AP) have higher levels of IFN-γ in the saliva compared to subjects without AP; this 
decrease was statistically significant throughout the course of treatment (p < 0.05).
3.2.2 Metalloproteinases
Matrix metalloproteinases (MMPs) are key proteases involved in destruc-
tive periodontal diseases. A total of 23 MMPs have been described. These MMPs 
can be found in periodontal tissues as pro-forms, active forms, complex species, 
fragmented, and cell-bound species [59]. MMPs are the most important group of 
proteinases responsible for the degradation of extracellular matrix proteins during 
periodontitis, and any imbalance between MMPs and their inhibitors can trigger 
the degradation of the ECM, the basement membrane, and the alveolar bone [60].
In this way and due to the importance of MMPs, several researchers have been 
dedicated to try to determine if MMPs are opportune as biomarkers. Gursoy et al. 
[61] did a study with the objective of detecting possible markers of periodontitis 
in saliva, with high sensitivity and specificity; to determine this, the salivary 
concentrations of MMP-8, MMP-9, and MMP-13 among others were measured in 
230 subjects. The concentrations of MMP-8, MMP-9, and MMP-13 in saliva were 
higher in subjects with generalized periodontitis than in controls; however, accord-
ing to the authors, MMP-8 was the only marker capable of differentiating subjects 
with severe bone loss of those who presented mild bone loss, so they consider that 
MMP-8 is a strong candidate to detect alveolar bone destruction [61]. These results 
were corroborated by Rathnayake et al. [46] who found that MMP-8 could be used 
as a marker of periodontal disease in large patient populations. An interesting fact 
that they reported is that smokers compared to non-smokers showed slightly lower 
concentrations of MMP-8.
Another interesting fact regarding MMP-8 by Ebersole et al. [25] in a study that 
included 30 healthy volunteers and 50 patients diagnosed with chronic periodontitis 
is that MMP-8 (among others) was investigated as a biomarker associated with 
inflammatory and destructive processes of periodontal disease and reported that 
the levels of MMP-8 of patients who have periodontitis are very different from the 
normal levels found in healthy subjects and showed a particular diagnostic potential.
Morelli et al. [50] examined 168 participants and found higher salivary levels of 
matrix metalloproteinases, MMP-3, MMP-8, and MMP-9, in diseased groups com-
pared to healthy. In the same year, Miricescu et al. [62] carried out a study where 20 
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patients were also included with chronic periodontitis and 20 controls and different 
biomarkers were evaluated including matrix MMP-8, and as a result it was found that 
the levels of MMP-8 were significantly increased in patients with chronic periodonti-
tis compared to controls.
Ebersole et al. [43] conducted a study that included 65 healthy subjects, 43 
subjects with gingivitis, and 101 subjects with periodontitis. In this study, the levels 
of MMP-8 very similar to the previous studies stood out in a significant way in the 
group of periodontitis compared to those of gingivitis and healthy subjects. In a 
more categorical way, Borujeni et al. [63] reported that MMP-8 provides a substan-
tial sensitivity with which physicians can use the test for MMP-8 and thus detect 
periodontitis in their patients.
Similarly, Gupta et al. [64] made an investigation with the objective of 
establishing MMP-8 as a noninvasive marker for the early diagnosis of chronic 
periodontitis. The study included 40 subjects who were divided into two groups: 
20 healthy subjects and 20 patients with chronic periodontitis. The results of this 
study demonstrate high concentrations of MMP-8 in individuals with chronic 
periodontitis.
Already Lira et al. [65] continued to explore the importance of MMP-8 and 
conducted a study that aimed to evaluate the levels of markers related to innate 
immunity, the MMP-8 in the saliva from patients with aggressive generalized 
periodontitis, and patients with gingivitis and healthy. In the saliva, MMP-8 levels 
were higher in aggressive periodontitis than in healthy patients; in this way it is 
reaffirmed that MMP-8 can be an important biomarker of periodontitis.
Other researchers such as Virtanen et al. [66] continued to look for other metal-
loproteinases as potential biomarkers, and some reaffirm that the salivary concen-
trations of matrix metalloproteinases such as MMP-8 and MMP-9 are slightly higher 
in patients with periodontitis, although they report that the differences between the 
groups were not significant. Interestingly, this group reports that MMP-13 values 
were significantly higher in the group without periodontitis compared to patients 
with periodontitis and also report that the concentration of MMP-13 may have some 
gender implications in periodontitis.
Following with the MMP-8, Mauramo et al. [67] studied whether the levels of 
MMP-8 in the saliva are associated with periodontitis in 258 subjects. Periodontitis 
was more frequent among subjects with high levels of MMP-8 in the saliva. The 
highest levels of salivary MMP-8 were associated with any periodontal diagnosis 
(mild, moderate, or severe). They concluded that elevated levels of MMP-8 in the 
saliva are associated with periodontitis in a normal adult population.
3.2.3 Calcium
When we search for studies that have explored the detection of calcium present 
in saliva as a biomarker, we find that while some studies report the usefulness of 
calcium because the subjects in the periodontitis group had significantly higher 
levels of salivary calcium than gingivitis and healthy group [68, 69], another work 
find that high salivary calcium content can be correlated with good dental health 
but not with periodontal bone destruction [70].
3.2.4 Phosphorus
According to Patel et al. [69] study, phosphorus can be considered a biomarker 
for the diagnosis of sick and healthy periodontal tissues. The study concludes that 
as the severity of periodontal disease increases, it also increases total phosphorus 
levels.
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with severe bone loss of those who presented mild bone loss, so they consider that 
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patients were also included with chronic periodontitis and 20 controls and different 
biomarkers were evaluated including matrix MMP-8, and as a result it was found that 
the levels of MMP-8 were significantly increased in patients with chronic periodonti-
tis compared to controls.
Ebersole et al. [43] conducted a study that included 65 healthy subjects, 43 
subjects with gingivitis, and 101 subjects with periodontitis. In this study, the levels 
of MMP-8 very similar to the previous studies stood out in a significant way in the 
group of periodontitis compared to those of gingivitis and healthy subjects. In a 
more categorical way, Borujeni et al. [63] reported that MMP-8 provides a substan-
tial sensitivity with which physicians can use the test for MMP-8 and thus detect 
periodontitis in their patients.
Similarly, Gupta et al. [64] made an investigation with the objective of 
establishing MMP-8 as a noninvasive marker for the early diagnosis of chronic 
periodontitis. The study included 40 subjects who were divided into two groups: 
20 healthy subjects and 20 patients with chronic periodontitis. The results of this 
study demonstrate high concentrations of MMP-8 in individuals with chronic 
periodontitis.
Already Lira et al. [65] continued to explore the importance of MMP-8 and 
conducted a study that aimed to evaluate the levels of markers related to innate 
immunity, the MMP-8 in the saliva from patients with aggressive generalized 
periodontitis, and patients with gingivitis and healthy. In the saliva, MMP-8 levels 
were higher in aggressive periodontitis than in healthy patients; in this way it is 
reaffirmed that MMP-8 can be an important biomarker of periodontitis.
Other researchers such as Virtanen et al. [66] continued to look for other metal-
loproteinases as potential biomarkers, and some reaffirm that the salivary concen-
trations of matrix metalloproteinases such as MMP-8 and MMP-9 are slightly higher 
in patients with periodontitis, although they report that the differences between the 
groups were not significant. Interestingly, this group reports that MMP-13 values 
were significantly higher in the group without periodontitis compared to patients 
with periodontitis and also report that the concentration of MMP-13 may have some 
gender implications in periodontitis.
Following with the MMP-8, Mauramo et al. [67] studied whether the levels of 
MMP-8 in the saliva are associated with periodontitis in 258 subjects. Periodontitis 
was more frequent among subjects with high levels of MMP-8 in the saliva. The 
highest levels of salivary MMP-8 were associated with any periodontal diagnosis 
(mild, moderate, or severe). They concluded that elevated levels of MMP-8 in the 
saliva are associated with periodontitis in a normal adult population.
3.2.3 Calcium
When we search for studies that have explored the detection of calcium present 
in saliva as a biomarker, we find that while some studies report the usefulness of 
calcium because the subjects in the periodontitis group had significantly higher 
levels of salivary calcium than gingivitis and healthy group [68, 69], another work 
find that high salivary calcium content can be correlated with good dental health 
but not with periodontal bone destruction [70].
3.2.4 Phosphorus
According to Patel et al. [69] study, phosphorus can be considered a biomarker 
for the diagnosis of sick and healthy periodontal tissues. The study concludes that 
as the severity of periodontal disease increases, it also increases total phosphorus 
levels.
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3.2.5 Alkaline phosphatase
Alkaline phosphatase has been evaluated in saliva as a possible biomarker for 
the detection of periodontitis. Dabra and Singh [16] first study 20 healthy subjects 
with gingivitis, and 20 with chronic periodontitis were included. This investigation 
showed a statistically significant increase in alkaline phosphatase activities in the 
saliva of patients with periodontal disease compared to the control group. A recent 
study of Patel et al. [69] included 150 healthy subjects, 50 patients with chronic 
generalized gingivitis, and 50 with periodontitis. In this study it was shown that 
alkaline phosphatase can be considered for the diagnosis of diseased and healthy 
periodontal tissues; since as the severity of periodontal disease increases, it also 
increases alkaline phosphatase levels.
3.2.6 pH
The pH of the saliva has been evaluated, and it has been found that there is a sig-
nificant change in the pH depending on the severity of the periodontal condition, so 
the pH can be useful as a rapid diagnostic biomarker in the consultation. The study 
suggests that the pH becomes alkaline when patients have chronic gingivitis, but it 
becomes acidic when there is periodontitis [71].
3.2.7 Telopeptide (ICTP)
A 2015 study found that the concentrations of ICTP were higher in the group 
with periodontitis and lower in the group with healthy patients; this study suggests 
that the level of ICTP in saliva increases as the patient presents with gingivitis and 
periodontitis, since the periodontitis samples had the maximum concentration of 
salivary ICTP. The authors suggest that more studies with a larger sample size be 
conducted to establish a correlation between the concentrations of ICTP and the 
individual clinical parameters [72].
3.3 Biomarkers determined in crevicular fluid
In the oral cavity, we find three fluids: the gingival crevicular fluid, the serum, 
and the total saliva. The gingival crevicular fluid is an exudate, and at present the 
quantification of its constituents is a current method to identify specific biomarkers 
with a reasonable sensitivity [73].
The gingival crevicular fluid is an exudate secreted by the gums that can be 
found in the crevices located at the point where the gumline meets the teeth. The 
concentrations of this fluid are usually low but may increase when an inflammatory 
process occurs in the oral cavity [74].
It is considered that due to the noninvasive and simple nature of its collection, the 
analysis crevicular fluid can be beneficial in determining the periodontal status [75].
3.3.1 Proteins (cytokines) involved in the inflammatory process of periodontitis
Regarding the cytokines that have been evaluated, we can say that they are very 
similar to those that were evaluated in the saliva; besides that the results are also 
similar since it has been found that IL-β is the most important cytokine since diverse 
studies confirm high levels in periodontal disease compared to healthy [48, 76, 77].
In the same way it happens with IL-2 and IL-6, where several studies conclude 
that both interleukins are important as biomarkers to identify patients with peri-
odontal disease [48, 76, 78].
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Regarding MCP-1, the levels of this biomarker were significantly higher in 
crevicular fluid than healthy subjects (p < 0.001) [54].
Regarding IFN-γ and TNF-α, both biomarkers were significantly higher in 
patients with aggressive periodontitis; this correlates with the findings in saliva 
where both biomarkers were elevated in sick patients [48].
3.3.2 Metalloproteinases
With respect to metalloproteinases, studies of biomarkers in crevicular fluid 
have shown that MMP-7 could be useful as a potential new biomarker for peri-
odontitis [79]. Similar to that determined in saliva, MMP-8 is increased in patients 
with periodontitis and provides a good sensitive measure to establish differences 
between patients and healthy individuals [77]. It is also useful as a complemen-
tary tool in the periodontal diagnosis [67]. Another metalloproteinase  
that has proved useful is MMP-9. This metalloproteinase correlates with clinical 
measures and results in good sensitivity to predict the progression of periodontal 
disease [77].
3.3.3 Alkaline phosphatase
A study was conducted to determine the usefulness of alkaline phosphatase as 
a biomarker, and this study showed a correlation with the clinical characteristics 
when mediated in crevicular fluid [80].
3.3.4 miRNAs
According to Mico et al. [81], epigenetic regulation by miRNAs has not yet been 
studied in periodontal disease using crevicular fluid. They analyzed the possible use 
as biomarkers of six miRNAs: miR-671, miR-122, miR-1306, miR-27a, miR-223, and 
miR-1226. Of the six miRNAs analyzed, only miR-1226 can be used as a promising 
biomarker for periodontal disease since it had statistically significant differences 
between the healthy group and patients with periodontitis.
3.3.5 Oxidative stress
As previously mentioned, 8-OhdG is a marker of DNA damage and is considered 
a biomarker to detect oxidative stress [24], that is why it is not surprising that its 
usefulness as a biomarker of periodontitis was explored. This study was conducted 
in crevicular fluid, and it could be determined that evaluating this biomarker in 
crevicular fluid is more effective than in saliva and that it can be useful as a bio-
marker for determining periodontitis since according to the authors, the severity of 
the periodontal disease can be revealed [82].
3.3.6 Telopeptide
Telopeptide has also been evaluated as a biomarker in periodontitis in the study 
by Aruna [83], which suggests that this biomarker could be useful as a specific 
marker of bone turnover in patients with periodontitis.
3.3.7 Other markers of periodontal disease
Chondroitin sulfate is a biomarker that, due to its results in patients with chronic 
periodontitis, suggests that it is important in the diagnosis to evaluate the severity 
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a biomarker to detect oxidative stress [24], that is why it is not surprising that its 
usefulness as a biomarker of periodontitis was explored. This study was conducted 
in crevicular fluid, and it could be determined that evaluating this biomarker in 
crevicular fluid is more effective than in saliva and that it can be useful as a bio-
marker for determining periodontitis since according to the authors, the severity of 
the periodontal disease can be revealed [82].
3.3.6 Telopeptide
Telopeptide has also been evaluated as a biomarker in periodontitis in the study 
by Aruna [83], which suggests that this biomarker could be useful as a specific 
marker of bone turnover in patients with periodontitis.
3.3.7 Other markers of periodontal disease
Chondroitin sulfate is a biomarker that, due to its results in patients with chronic 
periodontitis, suggests that it is important in the diagnosis to evaluate the severity 
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of alveolar destruction [80]. MUC4 protein was measured in crevicular fluid and 
according to this study can be considered as a new biomarker to rule out patients 
with periodontitis from healthy ones (p < 0.01) [79].
3.3.8 Osteoprotegerin (OPG)
A final marker that we have considered for crevicular fluid is osteoprotegerin; 
this biomarker was studied by Kinney et al. [77]. They studied healthy patients, 
with gingivitis and periodontitis, finding that the biomarker OPG was elevated in 
patients with periodontal disease with a significant difference when compared with 
healthy patients, so they conclude that this biomarker has a good sensitivity to rule 
out periodontal disease of gingival health.
3.4 Biomarkers determined in serum
Serum in humans is a matrix commonly used in clinical and biological 
studies. Many authors recommend using the correct matrix. Both plasma and 
serum are derived from whole blood that has undergone different biochemical 
processes after blood extraction. The serum is obtained from the blood that has 
been clotted [84].
3.4.1 Proteins (cytokines) involved in the inflammatory process of periodontitis
In a study conducted by Nile et al. [85], interleukin IL-17 was identified as a 
reliable biomarker in 40 patients with chronic periodontitis, later these subjects 
underwent periodontal therapy, and the values of this interleukin decreased; thus, 
they consider that IL-17 can be a valuable protein to monitor healing processes after 
a periodontal intervention.
Another protein related to the immune response MCP-1 was studied by Boström 
et al. [86]. They studied healthy patients with periodontitis and detected that the 
MCP-1 protein was increased in the serum and inflamed connective tissue com-
paring it with healthy patients. In this way, they considered that MCP-1 can help 
identify patients with periodontitis.
3.4.2 Metalloproteinases
Within the metalloproteinases studied in serum, Lira et al. [65] reported that 
MMP-8 is elevated in patients with aggressive generalized periodontitis compared 
with the rest of the patients.
3.4.3 Oxidative stress
Sreeram et al. [87] studied the transpeptidase biomarker (GGT) in healthy 
subjects and with periodontitis. This biomarker showed elevated levels in patients 
with periodontitis with respect to healthy. Among the conclusions found in this 
study was the GGT is useful, economic, and easy to use.
Onder et al [88] studied 4-hydroxynonenal (4-HNE) as a biomarker in 
serum, concluding that biomarker 4-HNE was at high levels in patients with 
periodontitis.
In another serum study, other biomarkers of oxidative stress as total antioxidant 
capacity (TOS) and oxidative stress index (OSI) used in patients with periodontitis 
and healthy found high levels of TOS and OSI in patients with chronic periodontitis, 
this suggests that these biomarkers play important roles in periodontitis [89].
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3.4.4 Others
Calprotectin was studied by Lira et al. [65]; this biomarker was analyzed in patients 
with aggressive generalized periodontitis, found elevated levels in these patients 
compared with healthy and with gingivitis. In addition to the previous study, Nizam 
et al. [90] studied myeloperoxidase (MOP) and found that it increases in patients with 
generalized periodontitis compared to healthy ones; nevertheless Meschiari et al. [91] 
reported similar levels in patients with periodontitis and healthy. This discrepancy 
between both authors is possible due to the demographic variation and probably the 
anatomical site where the sample was extracted for analysis.
3.5 Biomarkers determined in plasma
Blood can be a universal reflection of the state or phenotype. Its cellular com-
ponents are erythrocytes, thrombocytes, and lymphocytes. The liquid portion is 
called plasma, when all the components are retained. The concentrations of various 
plasma components are routinely determined in clinical practice [92]. In this way, it 
is not surprising that biomarkers are sought in plasma.
3.5.1 Proteins (cytokines) involved in the inflammatory process of periodontitis
Among the cytokines evaluated in plasma, we can say that IL-8 and IL-10 were 
useful to discriminate patients with aggressive periodontitis from healthy ones, 
and we can add that they were interleukins different from those expressed in the 
crevicular fluid where IL-2 and IL-6 were relevant [78].
On the other hand, IFN-γ is a biomarker that has been determined in plasma and 
was significantly high in patients with aggressive periodontitis, this correlates with the 
findings in crevicular fluid where this biomarker was elevated in sick patients [78].
Regarding MIP-1α, when it was determined in plasma, it was determined that it 
could be useful to discriminate patients with aggressive periodontitis from healthy 
ones, since it was found to be elevated [78].
4. Discussion
Periodontitis is one of the most prevalent illnesses in humans [93]. One of 
the main challenges faced by the periodontics field is to improve the methods for 
diagnostic and prognostic of periodontitis [94]. Biomarkers, previously described, 
can be useful in monitoring the current state of the disease, the effectiveness of 
the treatment, and possibly predict the progression. However, currently the single 
ideal biomarker displaying high specificity and sensitivity for discriminating and 
monitoring this disease has not been determined. Thus, the combination of dif-
ferent biomarkers could be more advantageous than single biomarkers [93]. This 
would provide a more accurate panorama of the state of periodontal disease.
Classic methods for periodontitis diagnosis as the inspection and the palpation 
by the specialist can be relatively inaccurate. Additionally, the use of periodontal 
probes, and radiography could only provide information about previous periodon-
tal damage rather than the current state [93]. Thus, biomarkers have been proposed 
as complementary methods to defeat the mentioned limitations monitoring the 
clinical response to an intervention and future risk [95].
Desirable’s characteristics in test using biomarkers in periodontitis are easy to 
perform, rapid, and low cost, which could allow clinicians to perform early diagno-
sis and more effective personalized treatment.
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Different factors are involved in the development of periodontitis, and a com-
plex interaction between bacteria and immune system is observed. Additionally, 
periodontitis has been linked to at least 43 systemic diseases [96]. Thus, it is 
important to be careful when interpreting the results of biomarker tests because 
different factors could have a confounding impact on potential biomarkers [97]. 
Additionally, further large-scale studies are needed to prove specificity and sen-
sitivity of the biomarkers analyzed in periodontitis and for utilization in routine 
clinical practice in the future.
5. Conclusions
Currently, a number of biomarkers have been sought for the detection of 
periodontal disease, but so far an ideal biomarker has not been found that helps 
early detection of the disease; perhaps the combination of several is the most 
appropriate.
The search for biomarkers continues, we suggest for further studies in search of 
new biomarkers, it should be consider having a larger sample size, a random source 
and keep a follow-up.
6. Future recommendations
Periodontal disease is already a very common problem in many countries; due 
to the above, the monitoring and reduction of the progress of periodontitis through 
surveillance and health promotion are part of the national health goal of countries 
like the United States [98].
Due to this, there has been an exhaustive search in recent years of biomarkers 
obtained from various sources, with saliva being the most used; however, we believe 
that new studies should include groups of patients with gingivitis on a daily basis, 
since this is considered an intermediate phase in which the patient can (if he/she 
carries out good dental hygiene and continues the treatment) stop the development 
of periodontitis [42], so that limit levels of these biomarkers may be detected.
In addition to this, numerous studies have shown so far that among the best 
options for biomarkers are proteins such as IL-1β, MMP-8, and ICTP.
From our point of view, we should also include and explore molecules such as 
miRNAs and other noncoding RNAs such as lncRNA and circRNA, in addition to 
the classical molecules that are already known to directly participate in the develop-
ment of inflammatory pathology, since the study of these molecules could yield 
new perspectives on the development and progression of periodontal disease, which 
at some point may have important applications as biomarkers with leading activity 
in the development and manifestation of periodontitis.
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Periodontitis is a chronic inflammatory disease with multifactorial etiology. 
The anaerobic bacteria have been implicated as the main etiological factor for 
periodontal destruction. Not all the individuals having the similar amount of plaque 
and calculus develop the periodontitis. Thus, the host susceptibility to periodontal 
pathogens plays a significant role in the etiopathogenesis of periodontitis. The 
genetic factor is the major determinant of the host susceptibility. There are con-
tradictory results and varied results of the association of various genetic loci of 
different genes with periodontitis in different ethnic populations. This chapter will 
briefly discuss the various candidates’ gene approach in understanding the etio-
pathogenesis of periodontitis. This chapter also throws some light on the relation-
ship of the recent advances in genetic analysis like genome wide association studies, 
epigenetic regulation, and infectogenomics with periodontal destruction.
Keywords: gene polymorphisms, SNPs, periodontitis, genome wide association 
studies, infectogenomics, epigenetics
1. Introduction
The interplay among the immune system, microbiota, and lifestyle habits like 
smoking, alcoholism, stress, and diet that leads to constant changes in the host is 
regulated by genes. These genes encode immune receptors and various molecules 
involved in the signal transduction pathways that play an essential role in up regula-
tion or down regulation of the immune response essentially the inflammatory reac-
tion in response to a stimuli. Genetic research has focused on understanding how 
these responses work and also how these responses differ between different individ-
uals. In addition to playing a role in health, the genetic factors also plays a major role 
in disease susceptibility. This review focuses on the genetic aspects of periodontal 
diseases wherein researchers are currently focusing on genetic evidences to explain 
the difference in susceptibility to periodontal disease in different individuals.
Although very prevalent, periodontal diseases are not evenly distributed across 
populations. Few people, who do not have much contributing local factors such as 
plaque and calculus, still develop severe destruction of bone whereas some do not 
develop severe forms of periodontal diseases in spite of having a very poor oral 
hygiene. This differential expression of periodontitis leads researchers to question 
if genetics and heritability played a major role. The first evidence that genetics 
played a role in periodontal diseases emerged in the 1990s. Schafer et al. postulated 
that a key determinant of whether individuals developed periodontitis or not was 
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dependent on the way their bodies responded to the microbes [1]. Genetic factors 
and environmental factors determine the susceptibility to disease.
A biomarker is a substance that could indicate a biologic state and is an objective 
measure to evaluate the current and future disease activity. The National Institutes 
of Health Biomarkers Definitions Working Group in 1998 defined a biomarker as 
“a substance that is measured objectively and evaluated as an indicator of normal 
biologic processes, pathogenic processes, or pharmacologic responses to a thera-
peutic intervention.” These biomarkers could be determined in various biological 
media like saliva, serum, and gingival crevicular fluid in health as well as disease. 
Generally, a combination of biomarkers is used in order to predict disease activity.
Genetic susceptibility to multifactorial diseases like periodontitis is usually due 
to several gene polymorphisms instead of a single, or few, gene mutations. Subtle 
variations in the genetic code may result in altered expression of the encoded 
proteins, thereby making individuals with genotypes more susceptible to a given 
disease.
The genetic link with the etiopathogenesis of periodontitis was started with the 
initial finding of association of composite genotype (Interleukin-1α and IL-1β) with 
chronic periodontitis in Caucasian population by Kornman et al. [2]. Following 
him, lot of studies conducted in different ethnic races linking the association 
of composite genotype with periodontitis. But the results were contradictory in 
nature. A variety of single nucleotide polymorphisms of various signaling factors, 
receptors, connective tissue components, enzymes involved in the host defense 
against the invading microbes have been reported by several researchers. Use of the 
genetic risk score could be useful in assessing the susceptibility to periodontitis. 
However, conflicting results have been reported because of the heterogeneticity of 
the studies. Different variations in frequency of some alleles in different popula-
tions have been observed.
2. Candidate gene approach
2.1 Interleukin-1
Interleukin-1 (IL-1) is a pro-inflammatory cytokine, which is encoded by IL-1 
gene cluster at the chromosomal position 2q13–21. It is produced by inflammatory 
cells such as monocytes, macrophages, and dendritic cells, which play an important 
role in the regulation of immune and inflammatory responses to infections. It is 
composed of two molecules, IL-1α and IL-1β. The former regulates intracellular 
events while the latter acts as an extracellular protein. It plays a major role in the 
regulation of the inflammatory mechanisms. Studies by Lavu et al., Hao et al. have 
proposed that IL-1 cluster gene single nucleotide polymorphisms were associated 
with higher risk for periodontitis [3, 4]. Kornman et al. reported a relationship 
between IL-1α −889 and IL-1β +3954 and the severity of periodontal disease [2].
Kobayashi et al. demonstrated that Asians had a low carriage rate of IL-1α −889 
R-allele compared to the other populations [5]. A meta-analysis by Mao et al., 
showed that IL-1β +3954 polymorphism increases the risk of periodontal disease 
[6]. Other authors like Amirisetty et al., Masamatti et al. suggested a strong 
association of IL-1β −511 and +3954 with chronic periodontitis in Indians [7, 8]. 
Whereas the study by Kaarthikeyan et al. did not find any significant association 
between interleukin-1β (+3954) polymorphism with chronic periodontitis in 
Indian population [9].
Karimbux et al. in their systematic review and meta-analysis studied 13 studies 
and found that IL-1α and IL-1β (IL-1α (−889) C > T, IL-1α (+4845) G > T, IL-1β 
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(+3954) C > T, could be a significant contribution to the risk of developing peri-
odontitis [10]. Similarly, Yin et al. in their meta-analysis has found an association 
between IL-1α rs17561 and IL-1β rs 1143634 polymorphisms and periodontitis [11]. 
IL-1 gene cluster single nucleotide polymorphisms cannot be considered a signifi-
cant risk factor for all populations. They seem to contribute to risk of periodontitis 
in Asian populations.
2.2 Interleukin-6
Interleukin-6 is produced during inflammation by T cells. It is encoded by the 
IL-6 gene localized on chromosome 7p21. Interleukin-6 is a potent bone resorb-
ing cytokine. It activates and regulates the osteoclasts. Thus, this plays a major 
role in the susceptibility and progression of periodontal destruction. Zhang et al. 
found significant association between IL-6 −1363 G/T and IL-6R +48,892 A/C 
polymorphisms with periodontitis in Chinese population [12]. In a meta-analysis by 
Nikolopoulos et al. on cytokine gene polymorphisms such as IL-1α, IL-1β, IL-6, and 
TNF which included 53 studies, no significant association was detected between 
IL-6 and chronic periodontitis [13].
2.3 Interleukin-10
It is an anti-inflammatory cytokine expressed by T helper cells. It is encoded 
on gene at 1q31-q32. The major regions of interleukin-10 single nucleotide poly-
morphisms studied were −1082, −819, and −592. However, conflicting results have 
been obtained. Berglundh et al. found positive associations between IL-10 SNP and 
periodontitis in Swedish and Brazilian population [14]. Scarel-Caminaga et al. did 
not find any significant association in the Caucasian population [15].
2.4 TNF-α
It is a proinflammatory cytokine produced by macrophages. Gene localized at 
6p21.3. A meta-analysis by Nikolopoulos et al., which based on 17 studies showed 
that there was no association of the TNF-α promoter −308G/A polymorphism 
with periodontitis while another meta-analysis by Song et al. which also included 
17 studies found that TNF-α −308 A allele was associated with periodontitis in 
Brazilian, Asian, and Turkish populations [13]. Ding et al. in their meta-analysis 
based on 15 studies found an association between TNF-α SNP and periodontitis in 
Asian and Caucasian population [16]. Thus, the role of TNF-α SNP in the etiopatho-
genesis of periodontitis has to be explored with further studies.
2.5 TGF-β
It is a multifunctional cytokine that plays an important role in cellular differ-
entiation, apoptosis and angiogenesis. It exists in three isoforms TGF-β1, β2, and 
β3. Cui et al. in their meta-analysis found significant association between TGF-β 
SNP and periodontitis in Asian population. However, few other studies by different 
authors did not show any association.
2.6 IFN-γ
Produced by natural killer cells. The gene is located on chromosome 12q24. 
Heidari et al. found an association between IFN-γ SNP in Iranian population, while 
Holla et al. did not find any significant association [17].
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2.7 Vitamin D
Vitamin D and Vitamin D receptor are important mediators of bone metabolism. 
SNPs or dysfunction could lead to bone resorption. The gene encoding vitamin D is 
located on 12q12-q14.
Gross et al. in their study found that Fok1 polymorphism was associated with 
periodontitis. Brett et al. in their study found TaqI, BsmI, FokI and ApaI SNPs were 
associated with periodontitis [18]. Kaarthikeyan et al. did not find any significant 
association of VDR Taq1 polymorphism with periodontitis in south Indian popula-
tion [19]. Mashhadiabbas et al. in their meta-analysis based on 38 studies found an 
association of vitamin D receptor BsmI, TaqI, FokI, and ApaI polymorphisms with 
periodontitis [20].
2.8 Matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase
Matrix metalloproteinases (MMPs) are the key enzymes, which play a major role 
in the destruction of the collagenous and non-collagenous proteins of the connec-
tive tissue component. This is essential for maintaining the normal tissue homeo-
stasis. To date, at least 26 members of MMPs have been identified. In periodontitis, 
this tissue homeostasis is altered with more destruction of connective tissue 
components and less inhibition by the TIMPs. Elevated levels of MMP-1, MMP-
2, MMP-3, MMP-8, and MMP-9 have been detected in gingival crevicular fluid, 
peri-implant sulcular fluid, and gingival tissue of periodontitis patients. Thus, the 
genetic changes of the MMPs and TIMPs might play a role in the etiopathogenesis of 
periodontitis. According to Li et al., there was no significant association of MMP1, 
8, 9, 12, 2, or 13 polymorphism with periodontitis. They did a meta-analysis of 17 
studies [21]. Thus, the role of MMPs and TIMPs gene polymorphism with periodon-
titis has to be explored with further refined studies.
3. Genome wide association analysis
Rhodin et al. in their systematic analysis listed top genes NIN, ABHD12B, 
WHAMM, AP3B2, CPEB1, HGD, ZNF675, EMK1, TNFRSF10B, HTR4, WDR59, 
JDP2, OTOF, ANGEL2, etc. that showed evidence of association with severity of 
periodontitis and colonization of microorganisms [22]. GWAS is a recent devel-
opment in the field of research. It highlights suggestive loci that could play an 
important role in periodontitis. However, the method is expensive and technique 
sensitive. Many GWAS in periodontitis has been carried out and has shown differ-
ential expression of varied genes [23–26].
4. Epigenetic modifications
Epigenetic modifications such as DNA methylation, histone modifications and 
RNA-associated silencing (micro RNA) play a role in susceptibility to disease. These 
modifications express or repress certain genes.
Loo et al. in their study showed that methylation of E-Cadherin and COX-2 
was observed in periodontitis patients. Nahid et al. demonstrated the expression 
of miR-146a in infections caused by periodontopathic bacteria. Park et al. in their 
study observed that miRNA-132 played a major role in pathogenesis induced by 
P. Gingivalis. Several studies have reported the influence of various microRNAs 
especially miR-146a, let-7a, miR-196a, miR-499a, and miR-125a in susceptibility to 
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chronic periodontitis [27–29]. Priyanka et al. in their study have found association 
of microRNA-125a and microRNA-499a polymorphisms with chronic periodontitis 
in south Indian population [30].
5. Infectogenomics
Infectogenomics refers to the association of the host genetic variants like single 
nucleotide polymorphisms with the composition of the microbial complexes in the 
host body. The recent meta-analysis by Nibali et al. has shown an association of 13 
host genetic variants with the red/orange complex bacteria in periodontitis. The 
study by Divaris et al. has shown an association of two genetic loci (KCNK1 and 
DAB2IP) with high colonization of red complex bacteria. A more detailed knowl-
edge of the human oral microbiome could provide more information on its associa-
tion with host genetic variants [31, 32].
6. Conclusion
Although there are several studies that associate various candidate gene poly-
morphisms to periodontitis, till date there is not much clarity in the genetic suscep-
tibility to the disease since there are a multitude of etiological factors and epigenetic 
factors that contribute to the susceptibility as well as severity of periodontal disease. 
Future research should focus on the multitude of genes, their multiple interac-
tions and the epigenetic regulation during different stages of periodontal disease 
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Role of Radiographic Evolution: 




In periodontics, the main purpose of radiography is to detect the level of the 
alveolar bone including the pattern and extent of loss of the bone. Measurements 
which are of linear from the cement-enamel junction to the crest of the alveolar 
bone and from the cement enamel junction to the bone defect base are commonly 
used to measure the bone height and bone defects. In radiographs, the periodontal 
ligament space, lamina dura and periapical region are seen and also helpful in 
identifying risk, such as calculus and dislodged restorations. Radiographs can pro-
vide information for proper diagnosis and treatment planning, which can provide 
information for the assessment of accurate treatment outcomes.
Keywords: computed tomography, cone beam computed tomography,  
tuned aperture computed tomography, magnetic resonance imaging, ultrasonography
1. Introduction
Ever since the discovery of X-rays by Wilhelm Conrad Roentgen in 1895, the 
diagnostic capabilities of medical and dental professions has been revolutionized 
and forever changed the practice of medicine and dentistry. Substantial advances 
in X-ray generator and X-ray detector technology have resulted in significant dose 
reductions and improved image quality. These advances in oral radiography have 
transformed into meaningful clinical applications improving the way we prevent, 
diagnose and treat periodontal disease [1–3].
In periodontics, the main purpose of radiography is to detect the level of the 
alveolar bone including the pattern and extent of bone loss. Measurements which 
are of linear from the cement enamel junction to the crest of alveolar bone and 
from the cement enamel junction to the osseous defect base are commonly used to 
measure crestal bone levels and osseous defects [4–7]. In radiographs, the periodon-
tal ligament space, lamina dura and periapical region are evident and also useful in 
identifying risk factors, such as calculus and defective restorations [8].
Radiographs are valuable for diagnosis of periodontal disease, estimation of sever-
ity, determination of prognosis, and evaluation of treatment outcome. However, radio-
graphs are an adjunct to the clinical examination, not a substitute for it. Radiographs 
demonstrate changes in calcified tissue; they do not reveal current cellular activity but 
rather reflect the effects of past cellular experience on the bone and roots.
Radiographs can provide critical information for diagnosis and treatment plan-
ning, which can also serve as baseline information for the assessment of treatment 
outcomes [9–11].
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Periodontist need to understand the strength and weakness of diagnostic 
imaging and way the cost and benefits of the test before prescribing it. Prescribing 
the appropriate type and the number of radiographs is critical for optimizing the 
impact of radiographs on treatment out comes.
The adaption of imaging which is digital as a modality of radiographic assess-
ment of the feature, according to scientific evidence, has the potential to change 
the way to see the periodontal tissues. There is a little doubt that future periodontist 
will be using as advanced imaging modalities, either directly or indirectly [12].
2. Normal interdental bone
Evaluation of bone changes in periodontal disease is based mainly on the 
appearance of the interdental bone because the relatively dense root structure 
obscures the facial and lingual bony plates. The bone which is present interdentally 
normally is seen as a radiopaque line beside the periodontal ligament (PDL) and 
at the bone margin, called as the lamina dura. Because this thin line represents the 
cortical bone which lining the socket, and change in the angulation of the beam 
produce changes in its appearance [13, 14].
Crest of the interdental bone normally vary according to the convexity of the 
proximal tooth surfaces and the level of the cementoenamel junction (CEJ) of the 
approximating teeth. The faciolingual diameter of the bone is related to the width 
of the proximal root surface. The angulation of the crest of the interdental septum 
is generally parallel to a line between the CEJs of the approximating teeth. When 
there is a difference in the level of the CEJs, the crest of the interdental bone appears 
angulated rather than horizontal [15] (Figure 1).
3. Radiographic techniques
In conventional radiographs, periapical and bite-wing projections offer the 
most diagnostic information and are most commonly used in the evaluation of 
periodontal disease. To properly and accurately depict periodontal bone status, 
proper techniques of exposure and processing are required. The bone level, pat-
tern of bone destruction, PDL space width, as well as the radiodensity, trabecular 
pattern, and marginal contour of the interdental bone, vary by modifying exposure 
Figure 1. 
Crest of interdental bone normally parallel to a line drawn between the cementoenamel junction of adjacent 
teeth (arrow). Note also the radiopaque lamina dura around the roots and interdental bone.
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and development time, type of film, and X-ray angulation. Standardized, reproduc-
ible techniques are required to obtain reliable radiographs for pretreatment and 
posttreatment comparisons. Prichard put forward the following four criteria for the 
determination of adequate angulation of periapical radiographs [16–18]:
1. The periapical radiograph should have the ability to show the cusps of molars 
with occlusal surface.
2. Enamel and pulp chambers should be seen and distinct.
3. Open interproximal spaces.
4. Contacts between the adjacent teeth should not overlap unless teeth are out 
of line. For periapical radiographs, the long-cone paralleling technique most 
accurately projects the alveolar bone level.
The bisection-of-the-angle technique elongates the projected image, making 
the bone margin appear closer to the crown; the level of the facial bone is distorted 
more than that of the lingual. Inappropriate horizontal angulation results in tooth 
overlap, changes the shape of the interdental bone image, alters the radiographic 
width of the PDL space and the appearance of the lamina dura, and may distort the 
extent of furcation involvement [19].
Periapical radiographs frequently do not reveal the correct relationship between 
the alveolar bone and the CEJ. This is particularly true in cases in which a shallow 
palate or floor of the mouth does not allow ideal placement of the periapical film. 
Bite-wing projections offer an alternative that better images periodontal bone 
levels. For bite-wing radiographs, the film is placed behind the crowns of the upper 
and lower teeth parallel to the long axis of the teeth. The X-ray beam is directed 
Figure 2. 
Comparison of long-cone paralleling and bisection-of-the-angle techniques. (A) Long-cone paralleling 
technique, radiograph of dried specimen. (B) Long-cone paralleling technique, same specimen as A. Smooth 
wire is on margin of the facial plate and knotted wire is on the lingual plate to show their relative positions. 
(C) Bisection-of-the angle technique, same specimen as A and B. (D) Bisection of the-angle technique, same 
specimen. Both bone margins are shifted toward the crown, the facial margin (smooth wire) more than the 
lingual margin (knotted wire), creating the illusion that the lingual bone margin has shifted apically.
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through the contact areas of the teeth and perpendicular to the film. Thus the 
projection geometry of the bite-wing films allows the evaluation of the relationship 
between the interproximal alveolar crest and the CEJ without distortion. If the 
periodontal bone loss is severe and the bone level cannot be visualized on regular 
bite-wing radiographs, films can be placed vertically to cover a larger area of the 
jaws. More than two vertical bite-wing films might be necessary to cover all the 
interproximal spaces of the area of interest [20] (Figure 2).
4. Bone destruction in periodontal disease
Early destructive changes of bone that do not remove sufficient mineralized tis-
sue cannot be captured on radiographs. Therefore slight radiographic changes of the 
periodontal tissues suggest that the disease has progressed beyond its earliest stages. 
The earliest signs of periodontal disease must be detected clinically [16].
4.1 Bone loss
The radiographic image tends to underestimate the severity of bone loss. The 
difference between the alveolar crest height and the radiographic appearance ranges 
from 0 to 1.6 mm, mostly accounted for by X-ray angulation [21].
4.1.1 Amount
Radiographs are an indirect method for determining the amount of bone loss 
in periodontal disease; they image the amount of remaining bone rather than the 
amount lost. The amount of bone lost is estimated to be the difference between the 
physiologic bone level and the height of the remaining bone. The distance from  
the CEJ to the alveolar crest has been analyzed by several investigators. Most 
studies, conducted in adolescents, suggest a distance of 2 mm to reflect normal 
periodontium; this distance may be greater in older patients [22].
4.1.2 Distribution
The distribution of bone loss is an important diagnostic sign. It points to the 
location of destructive local factors in different areas of the mouth and in relation to 
different surfaces of the same tooth [23].
5. Pattern of bone destruction
In periodontal disease the interdental bone undergoes changes that affect the 
lamina dura, crestal radiodensity, size and shape of the medullary spaces, and 
height and contour of the bone. Height of interdental bone may be reduced, with 
the crest perpendicular to the long axis of the adjacent teeth horizontal bone loss; or 
angular or arcuate defects angular, or vertical, bone loss; could form [24–26].
Radiographs do not indicate the internal morphology or depth of craterlike 
defects. Also, radiographs do not reveal the extent of involvement on the facial and 
lingual surfaces. Bone destruction of facial and lingual surfaces is masked by the 
dense root structure, and bone destruction on the mesial and distal root surfaces 
may be partially hidden by superimposed anatomy, such as a dense mylohyoid 
ridge. In most cases, it can be assumed that bone losses seen interdentally continue 
in either the facial or the lingual aspect, creating a troughlike lesion [27].
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Dense cortical facial and lingual plates of interdental bone obscure destruction 
of the intervening cancellous bone. Thus a deep craterlike defect between the facial 
and lingual plates might not be depicted on conventional radiographs. To record the 
destruction of the cancellous bone which is present interproximally and radiograph-
ically, the cortical bone must be involved. A decrease of only 0.5–1.0 mm in the 
thickness of the cortical plate is sufficient to permit radiographic visualization of the 
destruction of the inner cancellous trabeculae. Interdental bone loss may continue 
facially and/or lingually to form a troughlike defect that could be difficult to appre-
ciate radiographically. These lesions may terminate on the radicular surface or may 
communicate with the adjacent interdental area to form one continuous lesion [28].
6. Radiographic appearance of periodontal disease
6.1 Periodontitis
Radiographic changes in periodontitis follow the pathophysiology of periodontal 
tissue destruction and include the following [29]:
1. Fuzziness and disruption of lamina dura crestal cortication continuity is the 
earliest radiographic change in periodontitis and results from bone resorption 
activated by extension of gingival inflammation into the periodontal bone. 
Depicting these early changes depends greatly on the radiographic technique, 
as well as on morphological changes. No correlation was found between 
Figure 3. 
Radiographic changes in periodontitis. (A) Normal appearance of interdental bone. (B) Fuzziness and a break 
in the continuity of the lamina dura at the crest of the bone distal to the central incisor (left). There are wedge-
shaped radiolucent areas at the crest of the other interdental bone. (C) Radiolucent projections from the crest 
into the interdental bone indicate extension of destructive processes. (D) Severe bone loss.
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periodontal bone loss is severe and the bone level cannot be visualized on regular 
bite-wing radiographs, films can be placed vertically to cover a larger area of the 
jaws. More than two vertical bite-wing films might be necessary to cover all the 
interproximal spaces of the area of interest [20] (Figure 2).
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difference between the alveolar crest height and the radiographic appearance ranges 
from 0 to 1.6 mm, mostly accounted for by X-ray angulation [21].
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amount lost. The amount of bone lost is estimated to be the difference between the 
physiologic bone level and the height of the remaining bone. The distance from  
the CEJ to the alveolar crest has been analyzed by several investigators. Most 
studies, conducted in adolescents, suggest a distance of 2 mm to reflect normal 
periodontium; this distance may be greater in older patients [22].
4.1.2 Distribution
The distribution of bone loss is an important diagnostic sign. It points to the 
location of destructive local factors in different areas of the mouth and in relation to 
different surfaces of the same tooth [23].
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In periodontal disease the interdental bone undergoes changes that affect the 
lamina dura, crestal radiodensity, size and shape of the medullary spaces, and 
height and contour of the bone. Height of interdental bone may be reduced, with 
the crest perpendicular to the long axis of the adjacent teeth horizontal bone loss; or 
angular or arcuate defects angular, or vertical, bone loss; could form [24–26].
Radiographs do not indicate the internal morphology or depth of craterlike 
defects. Also, radiographs do not reveal the extent of involvement on the facial and 
lingual surfaces. Bone destruction of facial and lingual surfaces is masked by the 
dense root structure, and bone destruction on the mesial and distal root surfaces 
may be partially hidden by superimposed anatomy, such as a dense mylohyoid 
ridge. In most cases, it can be assumed that bone losses seen interdentally continue 
in either the facial or the lingual aspect, creating a troughlike lesion [27].
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Dense cortical facial and lingual plates of interdental bone obscure destruction 
of the intervening cancellous bone. Thus a deep craterlike defect between the facial 
and lingual plates might not be depicted on conventional radiographs. To record the 
destruction of the cancellous bone which is present interproximally and radiograph-
ically, the cortical bone must be involved. A decrease of only 0.5–1.0 mm in the 
thickness of the cortical plate is sufficient to permit radiographic visualization of the 
destruction of the inner cancellous trabeculae. Interdental bone loss may continue 
facially and/or lingually to form a troughlike defect that could be difficult to appre-
ciate radiographically. These lesions may terminate on the radicular surface or may 
communicate with the adjacent interdental area to form one continuous lesion [28].
6. Radiographic appearance of periodontal disease
6.1 Periodontitis
Radiographic changes in periodontitis follow the pathophysiology of periodontal 
tissue destruction and include the following [29]:
1. Fuzziness and disruption of lamina dura crestal cortication continuity is the 
earliest radiographic change in periodontitis and results from bone resorption 
activated by extension of gingival inflammation into the periodontal bone. 
Depicting these early changes depends greatly on the radiographic technique, 
as well as on morphological changes. No correlation was found between 
Figure 3. 
Radiographic changes in periodontitis. (A) Normal appearance of interdental bone. (B) Fuzziness and a break 
in the continuity of the lamina dura at the crest of the bone distal to the central incisor (left). There are wedge-
shaped radiolucent areas at the crest of the other interdental bone. (C) Radiolucent projections from the crest 
into the interdental bone indicate extension of destructive processes. (D) Severe bone loss.
Periodontal Disease - Diagnostic and Adjunctive Non-surgical Considerations
54
lamina dura in radiographs and the presence or absence of clinical inflamma-
tion, bleeding on probing, periodontal pockets, or clinical attachment loss. 
Therefore it can be concluded that the presence of an intact crestal lamina dura 
may be an indicator of periodontal health (Figure 3).
2. Continued periodontal bone loss and widening of the periodontal space results 
in a wedge-shaped radiolucency at the mesial or distal aspect of the crest. The 
apex of the area is pointed in the direction of the root.
3. Subsequently, the destructive process extends across the alveolar crest, thus 
reducing the height of the interdental bone. As increased osteoclastic activity 
results in increased bone resorption along the endosteal margins of the medul-
lary spaces, the remaining interdental bone can appear partially eroded.
4. The height of the interdental septum is progressively reduced by the extension 
of inflammation and the resorption of bone.
5. Frequently a radiopaque horizontal line can be observed across the roots of a 
tooth. This opaque line demarcates the portion of the root where the labial or 
lingual bony plate has been partially or completely destroyed from the remain-
ing bone-supported portion [30–32].
7. Furcation involvement
Definitive diagnosis of furcation involvement is made by clinical examination, 
which includes careful probing with a specially designed probe (e.g., Nabers). 
Radiographs are helpful, but root superimposition, caused by anatomic variations 
and/or improper technique, can obscure radiographic representation of furcation 
involvement. As a general rule, bone loss is greater than it appears in the radio-
graph. A tooth may present marked bifurcation involvement in one film but appear 
to be uninvolved in another. Radiographs should be taken at different angles to 
reduce the risk of missing furcation involvement [31].
The recognition of a large, clearly defined radiolucency in the furcation area is 
easy to identify but less clearly defined radiographic changes are often overlooked. 
To assist in the radiographic detection of furcation involvement, the following 
diagnostic criteria are suggested [32]:
1. The radiographic change in the furcation area can be determined clinically, 
especially if there is bone loss on adjacent roots.
2. Reduced radiodensity in the furcation area in which bony trabeculae outlines 
are visible suggests furcation involvement of the teeth.
3. Whenever there is marked bone resorption in relation to a single molar root, it 
can be assumed that the furcation of it is also involved (Figure 4).
8. Trauma from occlusion
Trauma from occlusion can produce visible changes radiographically in the 
thickness of the lamina dura, morphology of the alveolar bone crest, width of the 
PDL space, and density of the surrounding cancellous bone [31].
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Traumatic lesions manifest more clearly in faciolingual aspects because mesio-
distally, the tooth has the added stability provided by the contact areas with adja-
cent teeth. Therefore slight variations in the proximal surfaces may indicate greater 
changes in the facial and lingual aspects. The radiographic changes listed next are 
not pathognomonic of trauma from occlusion and must be interpreted in combina-
tion with clinical findings, particularly tooth mobility, presence of wear facets, 
pocket depth, and analysis of occlusal contacts and habits [32].
The injury phase of trauma from occlusion produces a loss of the lamina dura 
that may be noted in apices, furcations, and marginal areas. This loss of lamina dura 
results in widening of the PDL space. The repair phase of trauma from occlusion 
results in an attempt to strengthen the periodontal structures to better support 
the increased loads. Radiographically, this is manifested by a widening of the PDL 
space, which may be generalized or localized [33].
9. Advanced procedures
9.1 Tomography
Tomography is a generic term formed by the Greek words “Tomo” (slice) and 
“Graph” (picture). So tomography refers to imaging by sections or sectioning, 
through the use of any kind of penetrating wave. A device used in tomography 
is called a tomography, while the image produced is a tomogram. Conventional 
film-based tomography, also called body section radiography is, a radiographic 
technique designed to image more clearly objects lying within a plane of interest. 
This is accomplished by blurring the images of structures lying outside the plane of 
interest through the process of motion “unsharpness.”
In conventional medical X-ray tomography, sectional image is taken through a body 
by moving an X-ray source and the film in opposite directions during the exposure.
9.1.1 Main indications
The main clinical indicated to examine various facial structures:
• When a pathology is strongly suspected clinically, but plain films are negative.
• Preoperative assessment of jaw height, thickness and texture before inserting 
implants.
Figure 4. 
Early furcation involvement suggested by fuzziness in the bifurcation of the mandibular first molar, 
particularly when associated with bone loss on the roots.
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• Postoperative evaluation of implants.
• Tomography of sinuses.
• Tomography of facial bones, to study facial fractures.
• Evaluation of grossly comminuted facial fractures to determine all the fracture sites.
• Assessment of the extent of orbital blow-out fractures.
• The most commonly used radiographic modality for demonstrating 
maxillo-facial.
• Fractures are conventional radiography and it is still believed to be the most 
reliable.
• Diagnostic tool.
• As an additional investigation of the TMJ and condylar head particularly useful if.
• Patients are unable to open their mouths.
9.1.2 Advantages
• It gives a more precise evaluation of sinus pathologies, which are poorly 
visualized on.
• Routine radiography.
• Assessment of the size, position and extent of antral tumors.
• Sphenoid and ethmoidal sinuses are more clearly visualized.
• Similar optimum definition is obtainable on each slice.
9.1.3 Disadvantages
• The radiation dose to the patient may be high.
• The technique is time-consuming.
• A high level of cooperation is required as the patient has to remain in the same 
position throughout the investigation.
• Images appeared to be blurred.
10. Computed tomography (CT)
10.1 Introduction
In April of 1972 Godfrey Hounsfield a senior research scientist at EMI limited in 
Middlesex, England announced the invention of a revolutionary imaging technique. 
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He referred this technique as computerized axial transverse scanning for which he 
received a Nobel prize in 1979. With this technique he was able to produce an axial 
cross sectional image of the head using a narrowly collimated, moving beam of 
X-rays [33, 34].
10.2 Cone beam computed tomography
In the last decade, cone-beam computed tomography (CBCT) has revolution-
ized the field of oral and maxillofacial imaging. However, CBCT finds application 
in almost every diagnostic task of clinical dentistry, including evaluation of 
periodontal and periapical structures. CBCT offers many advantages over con-
ventional radiography, including the accurate three-dimensional imaging of teeth 
and supporting structures. Although not recommended for every dental patient, 
CBCT avoids the problems of geometric superimposition and unpredictable 
magnification and can provide valuable diagnostic information in periodontal 
evaluation [35].
Periapical and bite-wing radiographs provide information mostly for the 
interdental bone. However, a three-wall defect that preserves the buccal and/or 
lingual cortices can be difficult to diagnose, and the buccal, lingual, and furcational 
periodontal bone levels are hard to evaluate in conventional radiographs. When 
clinical examination raises concerns for such areas, CBCT imaging can add diagnos-
tic value [36–39] (Figure 5).
11. Advantages of CBCT in dentistry
Being considerably smaller, CBCT equipment has a greatly reduced physical 
footprint and is ~20–25% of the cost of conventional CT. CBCT provides images 
Figure 5. 
Periapical radiograph (A) and sagittal (B), cross-sectional (C), and axial (D) cone-beam computed 
tomography (CBCT) sections of the mandibular right second molar. No pathology is detected on the periapical 
radiograph. However, CBCT images clearly illustrate a deep, vertical, three-wall defect on the distal surface of 
the mandibular right second molar (red arrow).
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of high contrasting structures and is therefore particularly well-suited towards the 
imaging of osseous structures of the craniofacial area. The use of CBCT technology 
in clinical dental practice provides a number of advantages for maxillofacial imag-
ing [40]. These include:
11.1 Rapid scan time
Because CBCT acquires all projection images in a single rotation, scan time is 
comparable to panoramic radiography. This is desirable because artifact due to 
subject movement is reduced. Computer time for dataset reconstruction however 
is substantially longer and varies depending on FOV, the number of basis images 
acquired, resolution and reconstruction algorithm and may range from ~1 to 
20 minutes [41, 43].
11.2 Beam limitation
Collimation of the CBCT primary X-ray beam enables limitation of the 
X-radiation to the area of interest. Therefore an optimum FOV can be selected for 
each patient based on suspected disease presentation and region of interest. While 
not available on all CBCT systems, this functionality is highly desirable as it pro-
vides dose savings by limiting the irradiated field to fit the FOV.
11.3 Image accuracy
CBCT imaging produces images with sub-millimeter isotropic voxel resolution 
ranging from 0.4 mm to as low as 0.09 mm. Because of this characteristic, subse-
quent secondary (axial, coronal and sagittal) and MPR images achieve a level of 
spatial resolution that is accurate enough for measurement in maxillofacial applica-
tions where precision in all dimensions is important such as implant site assessment 
and orthodontic analysis [42].
11.4 Reduced patient radiation dose compared to conventional CT
Published reports indicate that the effective dose (E) varies for various full field 
of view CBCT devices from 29 to 477 μSv depending on the type and model of CBCT 
equipment and FOV selected patient positioning modifications (tilting the chin) and 
use of additional personal protection (thyroid collar) can substantially reduce dose 
by up to 40%. These doses can be compared more meaningfully to dose from a single 
digital panoramic exposure, equivalent CT dose, or the average natural background 
radiation exposure for Australia (1500 μSv) in terms of background equivalent radia-
tion time (BERT). CBCT provides an equivalent patient radiation dose of 5–80 times 
that of a single film-based panoramic radiograph, 1.3–22.7% of a comparable conven-
tional CT exposure or 7–116 days of background radiation.
11.5 Limitations of CBCT imaging
While there has been enormous interest, current CBCT technology has some 
limitations related to the “cone beam” projection geometry, detector sensitivity and 
resolution which is contrast. These parameters create an inherent image “noise” 
that reduces image clarity such that current systems are unable to record soft tissue 
contrast at the relatively low dosages applied for maxillofacial imaging.
Another factor that impairs CBCT image quality is image artifact three types of 
cone-beam-related artifacts:
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Partial volume averaging: it occurs when the selected voxel resolution of the scan 
is greater than the spatial or contrast resolution of the object to be imaged.
Under sampling: under sampling can occur when too few basis projections are pro-
vided for the reconstruction. A reduced data sample leads to misregistration and sharp 
edges and noisier images because of aliasing, where fine striations appear in the image.
Cone-beam effect: the cone-beam effect is the major source of error, especially 
in the parts which are outside of the scan volume. Because of the divergence of as it 
rotates around the patient in a horizontal plane. The amount of data corresponds to 
the total amount of attenuation along a specific beam projection angle as the scan-
ner completes an arc. Because the outer row pixels record less attenuation, whereas 
more information is recorded for objects projected onto the more central detector 
pixels, which results in image distortion, streaking artifacts.
11.6 Advantages of CBCT
1. CBCT has a scanning time which rapid as in comparison with panoramic 
radiography.
2. It allows reconstruction with proper three dimensional and display from an angle.
3. Its beam collimation makes limitation of X radiation to the area of interest.
4. Images clarity produces images ranging from 0.4 mm to as low as 0.076 mm.
5. Radiation dosage of patient is reduced (29–477 μSv) in comparison with 
conventional CT (~2000 μSv). Patient radiation dose is six times lesser than 
normal CT, as the exposure time is ~18 seconds.
6. The units of CBCT reconstruct the projection data to provide inter relational 
images in three orthogonal planes (axial, sagittal, and coronal).
7. Reformation which is multiplanar is possible by sectioning volumetric datasets 
nonorthogonally.
8. Multiplanar image can be “thickened” by increasing the number of voxels.
9. Volume rendering which is 3D is processed by direct or indirect technique.
10. The three positioning beams make patient positioning easy.
11. Reduced image artifacts: CBCT projection geometry, together with fast acqui-
sition time, results in a low level of metal artifact in primary and secondary 
reconstructions.
11.7 Disadvantages
The only disadvantage is its cost. But considering the enormous benefits, this 
cost effect can be overlooked.
Indications of cone-beam computed tomography:
1. Assessment of the jaw which includes:
• Pathological lesions which are bone and soft tissue;
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• Alveolar ridge loss;
• Recognition of fractures and structural maxillofacial deformities;
• Assessment of the inferior alveolar nerve before extraction of mandibular third 
molar impactions.
12. Ultrasonography
Ultrasound imaging is easy to use for the detection of noninvasive and soft 
tissue related diseases. Ultrasonography utilizes sound waves for image produc-
tion. The first major attempt at a practical application was made in search for the 
sunken Titanic in the North Atlantic in 1912. A few early attempts at applying US in 
medical diagnosis. Successful medical application began shortly after the war in the 
late 1940s and early 1950s. The vital ingredients are transducer, ultrasonic beam, 
a cathode ray tube or television monitor. The evolution of sonic imaging began 
slowly from a static one dimensional base (A-mode or amplitude mode), improved 
somewhat when a component of motion was added (TM-mode), made a giant leap 
forward with two dimensional imaging (B mode or brightness mode) and reached 
its current zenith with gray scale imaging. The phenomenon sound which are 
perceived is the result of changes which are periodic in the pressure of air against 
the eardrum. The periodicity of these changes ranging from 1500 to 20,000 cycles 
per second (hertz [Hz]). By definition, ultrasound has a periodicity >20 kHz. Thus 
it is distinguished from other waveforms which are mechanical simply by having a 
vibratory frequency more than the human audible range. Diagnostic ultrasonogra-
phy (sonography), uses vibratory frequencies in the range of 1–20 MHz. Scanners 
which are used for sonography generate impulses which is electrical that are 
converted into sound waves which is of high frequency help of a transducer.
Transducer is a device that transform one form of energy into another-in this 
case, electrical energy can be converted into sonic energy. The most important 
part of the transducer is a thin piezoelectric crystal or material which is made up 
of a great number of dipoles arranged in a pattern of geometric. A dipole may be 
thought of as a distorted molecule which has two ends that appears to have a posi-
tive charge on one end and a negative charge on the other.
Applications of ultrasound in periodontics:
1. As diagnostic aid: ultrasonography probe gives a system of mapping for 
noninvasive procedure and calculate as well as record various measurements 
of subject’s periodontal ligaments relative to a fixed point such as cementoe-
namel junction. This probe uses ultrasound to detect periodontal ligament and 
cement-enamel junction. This ultrasound probe records a series of measure-
ments which is painless.
2. Assessment of periodontium: an ultrasonic scanner that functions at a 
frequency of 29 MHz has been used to detect the dimensional relationship 
between hard and soft structures of periodontium. This device also used to 
assess the gingival thickness before and after mucogingival surgery for gingival 
recession and to calculate the thickness of masticatory mucosa.
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3. Detection of subgingival calculus: there are large number of subgingival calcu-
lus detection systems available found that dental surfaces may be determined 
separately by the tip oscillations analysis of an ultrasonic instrument, which 
has features of subgingival calculus detection.
4. Complete removal of dental plaque or the biofilm: removal of the bacterial 
plaque by means of the acoustic micro-streaming and cavitation effects of 
ultrasound. Many studies have shown that there is no statistically significant 
difference in the effectiveness of plaque removal using hand or motor driven 
instruments. It can also used for scaling in cases of necrotizing ulcerative 
lesions as this possess an action of lavage.
5. Removal of supra and subgingival calculus: cavitation effect liberates energy 
that can be able to remove the deposits. It is effective on the both supra and 
subgingival calculus, a direct contact between the vibrating tip and the calcu-
lus is needed.
6. Clearance of endotoxin and detoxification: the endotoxins are known to be 
fragments of bacterial cells and toxic products of bacteria and can be found in 
the root cementum or dentine, saliva and gingival crevicular fluid. Endotoxins 
are cytotoxic substances and can affect the immune system of the host. It is 
suggested that, for the successful treatment outcome, the infected dentine and 
altered cementum have to be removed. Recent studies have shown that endo-
toxin is superficially associated with the cementum and calculus. They can 
be easily removed by rinsing, brushing, lightly scaling, or polishing the root 
surface. Heat generated from magnetostrictive units may helpful in endotoxin 
removal or detoxification.
7. Curettage: ultrasound is effective for the debridement of the epithelial lin-
ing of periodontal pockets. A Morse scaler-shaped or rod-shaped ultrasonic 
instrument can be used. Ultrasonic instruments are found to be as effective as 
curettage done by hand instruments.
8. Osseous surgery: ultrasonic bone cutting surgery has been recently introduced as 
an alternative to the conventional techniques. Piezosurgery® is a new and inno-
vative method that uses piezoelectric ultrasonic vibrations to do precise and safe 
osteotomies. Piezoelectric surgery uses a specifically engineered surgical instru-
ment characterized by a surgical power that is three-times higher than normal 
ultrasonic instruments. The unique feature of this technique is that the cutting 
action occurs when tool is employed on the mineralized tissue, but stops when 
soft tissue is encountered. This technique can be used for preprosthetic surgery, 
sinus elevation procedure, implant placement as well as alveolar crest expansion.
13. Conclusions
Periapical radiographic examination should be part of each patient’s periodontal 
evaluation and should be coupled with a detailed recording of pocket depths, 
gingival margin location, and bleeding on probing. Radiographic evaluation should 
be updated every 2 years. Periapical radiographs often underestimate the amount 
of periodontal bone loss, and early changes are usually not detected. Significant 
interdental bone loss can occur and may not be detectable on periapical radiographs 
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because the density of the intact buccal and lingual or palatal bone plates obscure 
changes that occur as the result of periodontitis. Comparison of periapical radio-
graphs of the same area taken at different times will only be reliable in documenting 
dramatic changes in bone levels since variations in angulation of the beam, place-
ment of the film, and development of the image make accurate measurements taken 
over time very difficult and unreliable.
Recent use of three-dimensional radiographic techniques with CBCT gives a 
much more accurate picture of periodontal bone loss than do two-dimensional 
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The bidirectional relationship between local and systemic pathways makes 
it difficult to provide a safe intraoral treatment. Nowadays, mesotherapy has 
become more necessary in dentistry to overcome the huge number of surgical 
interventions either for therapeutic or for cosmetic purposes. It also limits the 
need for systemic drugs achieving favorable outcomes with minimal side effects. 
Further researches are needed to examine the usage of mesotherapy in different 
oral problems. In dermal mesotherapy, dermatologists used several materi-
als as hyaluronic acid, collagen, hydroxyapatite, carboxymethyl cellulose, and 
silicone. Such materials exhibit different manners according to their resorption 
rate: temporary, semipermanent, permanent, and combinations. Furthermore, 
B-tricalcium phosphate and hydroxyapatite are considered as tissue stimulators by 
stimulation of collagen formation. Combinations of temporary materials in order 
to achieve immediate filling effect with tissue stimulator as HA or B-TCP achieve 
better results.
Keywords: oral mesotherapy, intraepidermic injection, minimally invasive 
techniques, vitamins, tooth traction, depigmentation, connective tissue thickening
1.  An overview on the original mesotherapy technique for 
dermatological uses
The aim behind mesotherapy was to create a new technique, which favors the 
supplementation of needed agents directly and locally to the site of complaint. As 
previously mentioned, the proposed theory by Pistor depends mainly on the direct 
effect of the used drug on the tissue originating from the mesoderm [1, 2]. The 
mesoderm is one of the primary germ layers of the embryo that is responsible for 
the development of skin, connective tissue, muscles, tendons, and circulatory sys-
tem. It is mainly responsible for skin vitality and health [3]. The injection technique 
of mesotherapy depends mainly on the anatomical, histological and geometrical 
landmarks of the target tissues. Mesointerface is the horizontal interface between 
the injected agents and the injected region. For maximum benefits, the injected 
surface is inversely proportional to the amount and molecular weight of the injected 
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agent. The wider the mesointerface is, the greater the number of the dermal recep-
tors that are activated [4].
On the other hand, the vertical component depends on the depth of penetration. 
Mesotherapy could be injected in the epidermis, dermis, or subcutaneous [1]. The 
more superficial injection is, the longer the drug remains in the tissue. It permits 
sustained release of the drug with slow and progressive diffusion into the surround-
ing tissues [2, 5, 6].
The technique depends on the skin characteristics and components. It deter-
mines the type of drug injected, the technique of injection, and the drug dosage. 
The skin has a natural sustained releasing property. Therefore, the nature of the 
skin determines the layers that are suitable for injection. The injection process must 
be in the superficial layers (intradermal) for the drug to remain as long as possible 
and for its clearance to become slower. If the drug is injected deeper, its clearance 
becomes faster. So the more superficial the injection is, the longer the drug remains 
in place (being far more powerful and efficient) [6].
2. FDA and mesotherapy
The FDA is the association concerning about the assurance of the food and drug 
safety. Although FDA did not approve the mesotherapy technique, it approved 
many drugs that have been used in mesotherapy as aminophylline, yohimbine, 
procaine, lidocaine, and marcaine [7]. Other drugs do not have the FDA approval 
for any purpose of usage as it is beyond the scope of FDA because they do not 
consider drugs as vitamins and minerals [8]. It also approved the delivery method 
using mesogun [1].
All the drugs used in mesotherapy are considered by the FDA as off-label used 
drugs. The off-label approval includes the approved drug and the approved route of 
administration of this drug. The local anesthetic agents calcitonin, hyaluronidase, 
and collagenase are not approved by the FDA [9].
3. Benefits and uses of mesotherapy
The local treatment in mesotherapy has superior advantages over the sys-
temic one either oral or parental. Firstly, it avoids the side effects resulted from 
drug metabolism and excretion in the stomach, intestine, liver, and kidneys. 
Secondly, the effectiveness of the local drug is directly administrated into the 
area of interest. Finally, it minimizes the dosage used into 1% of the dosage used 
systemically [1].
Improvement of blood flow, removal of fibrotic tissue, an increase in the con-
nective tissue quality and amount, hair loss (mesohair), skin rejuvenation (meso-
glow), excessive fat and cellulite removal, improvement of the lymphatic drainage, 
osteoarthritis, and pain relief are the main medical indications of mesotherapy [10]. 
On the financial point of view, it is a cost-effective modality that provides success-
ful drug delivery using inexpensive equipment with short-term practice needed for 
the general practitioner [11].
Oral mesotherapy is an old technique which was commonly applied in order to 
introduce various agents. Infiltration, intraligamentary, intramucosal, intralesional, 
and intraepidermic injection are common names for oral mesotherapy technique 
that have been used previously. The different names were more related to different 
layers and structures of the oral cavity.
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4. Common agents delivered by oral mesotherapy
4.1 Local anesthesia
Local anesthesia is a reversible blockage of nerve conduction in a defined area 
that resulted in loss of sensation [12]. It can be performed using various techniques 
which differ according to the width of the area needed to be anesthetized as well as 
tissue depth and its relation to target nerve.
Local infiltration is one of the techniques in which the local anesthetic solution 
is administrated submucosal, intradermal, or intraligamentary in order to anesthe-
tize the nerve endings that innervate the target region. The submucosal injection 
involves the drug administration in the deep dermis layer reaching the lipid layer 
with 45 angulation and thicker needle, while the intradermal injection involves 
introduction of anesthetic agent into the superficial dermis (papillary dermis) 
with 10 to 15 degrees using fine needle [13, 14]. Intraligamentary (or periodontal) 
anesthesia is a type of the locally delivered anesthetic technique in which the needle 
is introduced in the mesiobuccal and distobuccal directions delivering the anes-
thetic agent in an apical direction. Its accuracy, easiness, minimal administration of 
anesthetic solution, efficiency, and the lack of harmful effects to the adjacent peri-
odontal apparatus are the main advantages of this technique [15, 16]. The pressure 
needed for such technique is necessary, and it remains the main cause behind the 
development of local inflammation and pain which may last up to 7 days as well as 
bone and root resorption in relation to the injection site [17]. Defective enamel dis-
orders were also detected following intraligamentary injection of local anesthesia. 
In hemophilic patients, intraligamentary injections are usually not recommended to 
avoid hematoma formation. It was also avoided in deciduous teeth [18] (Figure 1).
On the other hand, the field block technique involves the introduction of the 
anesthetic agent in a circular configuration around the operative site [19].
The interseptal technique is a simple technique which provides adequate control 
of pain and bleeding especially during emergency conditions. During infection and 
inflammatory conditions, interseptal technique is usually preferred. A 27 gauge 
needle is inserted at 45° at the center of the interdental papilla. Minimal amount 
(0.2–0.4 ml) of the anesthetic agent is injected. It was found that interseptal tech-
nique showed higher anesthetic efficiency than the intraligamentary and intraosse-
ous injection [18, 19].
The intrapulpal technique is one of the most common techniques that are used 
during endodontic treatment especially in acute phases of pulpal inflammation. 
Figure 1. 
Intraligamentary injection [18].
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Despite its rapid onset, effectiveness, and safeness, its action has shorter dura-
tion than other techniques [18]. Finally, the intraosseous technique provides rapid 
introduction, which is commonly used following failure of the field or nerve block 
technique. It depends on the direct introduction of the anesthetic agent to the 
interdental bone resulting in rapid delivery of the anesthetic agent to the blood 
circulation which should be avoided in cardiovascular patients [19] (Figure 2).
4.2 Corticosteroids
Corticosteroids are widely used for the management of numerous oral inflam-
matory conditions due to their anti-inflammatory and immune modulatory effects. 
They could be delivered either intramucosally (within the lesion), topically, or 
systemically [20].
Intralesional (intradermal) corticosteroid injection is a favorite method in 
delivering the drug directly to the target site resulting in rapid action as well as less 
systemic complications. Injectable steroids are clear fluids; their color and dose 
depend on the formulation of steroids used. It is commonly used in managing the 
longstanding oral lichen planus lesions and oral submucous fibrosis, but it has a 
localized side effect such as mucosal atrophy [21, 22]. Hydrocortisone and triam-
cinolone are the commonest formulas used in local delivery with weekly injections 
reaching up to 11 injections [22, 23].
Although surgical excision is considered the gold standard technique for treat-
ing mucocele and orofacial granulomatosis, the use of intralesional corticosteroid 
injection was also reported. However, some investigators have suggested that the 
intralesional corticosteroid could be used as a new modality in the treatment, but 
cases of relapse with corticosteroid have been reported [24, 25]. Great differences 
were detected in the used doses and the number of sessions according to the sever-
ity, extension, and the systemic condition of the patient [22, 23, 26–28].
4.3 Vitamins
According to literature, vitamins were usually introduced either by intraliga-
mentary or intraepidermic techniques. The intraepidermic technique was con-
ducted in 2016 by Yussif et al. [29].
4.3.1 Vitamin D
Although vitamin D has a great role in maintaining the bone health and metabo-
lism, it is just recently discovered that vitamin D deficiency has a great role in the 
occurrence and progression of various periodontal diseases. It is a steroid hormone 
that controls the bone metabolism and calcium homeostasis [30–32].
Figure 2. 
Corticosteroids and chronic gingival inflammation.
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It was detected that the level of vitamin D reaches its lowest levels during 
periodontal disease especially aggressive periodontitis. The daily supplementation is 
important to maintain the periodontal health [30–33].
The introduction of locally delivered vitamin D injections provides short treat-
ment visits, non-traumatic, less patient morbidity, non-stressful procedure with no 
post-operative side effects. The procedure is not painful. There is also no need for 
preoperative local anesthesia. It could be either delivered alone [34] or in combina-
tion with calcium [35]. The promising improvement of the regenerative power 
was attributed to minimal trauma and preserving the periosteum adapted over the 
alveolar bone. Great reduction of the clinical attachment loss and the absence of 
bleeding on probing were also detected indicating the absence of inflammation. On 
the radiographic examination, improvement of the alveolar bone density as well as 
accentuation of lamina dura was also reported [34, 35].
In orthodontic therapy, locally delivered vitamin D is commonly introduced in 
small doses using periodontal injection technique in order to accelerate the osteo-
clastic activity in the pressure site which in role accelerates the orthodontic move-
ment. The dose and the number of the treatment sessions are determined according 
to the distance that the tooth needed to travel [34, 36] (Figure 3).
4.3.2 Vitamin C
Ascorbic acid is also an essential vitamin in the treatment of periodontal dis-
eases. Its deficiency causes impaired wound healing with higher bleeding index. 
Lower levels of serum vitamin C were reported in periodontitis. The importance of 
vitamin C lies behind its powerful scavenging and antioxidant effect as it usually 
Figure 3. 
Vitamin D injection and periodontitis [37].
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accumulates in the immune cells as PMNs and macrophages and significantly 
enhances chemotaxis, phagocytic, opsonization, degranulation, and killing func-
tions of immune cells [33, 38]. It also has a great role in collagen biosynthesis [39]. It 
could be supplied orally, topically, or by intraepidermal injection [37, 40]. Vitamin 
C is widely used in dermal mesotherapy as it restores the tissue integrity and bright-
ness by neutralizing the free radicals in the newly formed tissues, stimulates the 
collagen formation, and inhibits melanogenesis [10, 41].
Growing evidence has suggested the role of vitamin C in enhancing the quality 
and outcome of the orthodontic treatment. This is proven when tooth movement 
was enhanced following systemic administration of vitamin C for 17 days [42, 43]. 
It was also noticed that its deficiency is accompanied with limited tooth movement 
and arrested osteogenesis [44].
Vitamin C induces its action through modifying the osteoclastic activity, 
osteogenesis, tissue healing, and periodontal ligament organization. It increases 
the collagen I synthesis that represents the main component of bone matrix and 
periodontal ligament [45]. It also accelerates the bone mineralization, calcium 
absorption, formation of collagen type X, expression of alkaline phosphatase, and 
osteoblast growth and differentiation [46, 47] (Figure 4).
Furthermore, the depigmenting effect of vitamin C depends mainly on its 
antioxidant property. The efficiency of vitamin C in the treatment of physiologic 
or pathologic dermal problems such as hyperpigmentation, aging, and dryness was 
promising due to several factors that are not only related to its direct interaction 
with melanin and melanocytes but also due to the overall effect on the applied 
tissues. Once vitamin C is introduced to the target tissue, it binds efficiently to 
melanin because melanin is the main store of ROS, calcium, and copper content 
that causes intracellular deficiency of these items. Lower intracellular calcium level 
causes failure of melanocytes to perform cellular adhesion as calcium is essential 
to form cadherins [48, 49]. The contact to keratinocytes is important simulator to 
Figure 4. 
Pre- and postoperative local vitamin C injection in impacted canine traction [37].
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melanocytes to produce melanin, formation of dendrites and transfer the produced 
melanin to neighboring cells [48, 50]. Also, shortage of the intercellular copper 
limits the formation of tyrosine, tyrosinase enzyme, and peroxidase enzyme which 
in turn stops the melanin production [41].
Pain and itching were regarded as painful stimuli. Itching may transit to pain due 
to increased discharge frequency of nociceptors (intensity theory) [51] (Figure 5).
In 2016, Yussif et al. used the intraepidermic injection technique (oral meso-
therapy technique) in order to treat physiological hyperpigmentation. Vitamin 
C injection is a safe, minimally invasive nonsurgical depigmenting technique 
which also improves health of gingival tissues. They concluded that the direct 
effect of vitamin C could be due to the affinity of melanin to react with it, which 
in turn affects the cellular junctions (causing the immediate fainting) and forces 
such cells to spell out their contents of melanin leading to tissue darkening after 
a while. Further investigations and studies are recommended to detect its long-
term effect on the melanocytes and keratinocytes [29] (Figure 6).
During persistent gingival inflammation, Yussif et al. [45] have reported signifi-
cant enhancement of the gingival health by the usage of the intraepidermic vitamin 
C injection as an adjunctive approach for the conventional nonsurgical treatment 
modality.
During inflammation, it was found that the tissue antioxidant level (as vitamin 
C, vitamin E, etc.) decreases rapidly indicating the need of its supplementation. 
On the other hand, the free radical production increases at the site of inflamma-
tion [52, 53]. Extra doses of antioxidants especially vitamin C are essential. In 
localized inflammatory conditions, the administration of the needed higher doses 
via systemic route (higher than 500 mg) cannot be absorbed by the gastrointesti-
nal tract, which is easily excreted through urine. Moreover, in order to reach this 
dose at the site of inflammation, it needs administration of very high systemic 
doses that could be harmful to the patient. The local injection provides the needed 
dose efficiently [54] (Figure 7).
In 2014, [55] reported that the switch of the gingival tissue to the thick biotype is 
important to gingival and periodontal health as well as esthetic outcome. Ascorbic 
acid enhances the periodontal ligament maturation and renewal by induction of the 
collagen formation especially collagen III (young collagen) and keeps the balance 
between collagen I (mature collagen) and III for tissue maturation. It also modifies 
the rate of fibroblast proliferation [56]. In 2016, Yussif et al. reported the improve-
ment of the gingival biotype following the intraepidermic vitamin C injection 
ranging between 0.5 and 1 mm [29].
Figure 5. 
Pre- and postoperative histopathological photos of local vitamin C injection in treatment of gingival 
hyperpigmentation [29].
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accumulates in the immune cells as PMNs and macrophages and significantly 
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Figure 4. 
Pre- and postoperative local vitamin C injection in impacted canine traction [37].
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melanocytes to produce melanin, formation of dendrites and transfer the produced 
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in turn stops the melanin production [41].
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4.4 Autogenous blood products
Platelet-rich plasma (PRP) is defined as a portion of the plasma element of 
autologous blood having a platelet concentration above baseline [56, 57]. It is 
considered as a growth factor agonist [58] with both mitogenic and chemotactic 
properties [56].
It was found that intralesional injection is a newly described method for applica-
tion of PRP and represents an effective therapeutic option when dealing with non-
healing wounds [59]. These findings open the door for using intralesional PRP in 
oral chronic ulcers. In 2015, El-Komy and his colleagues conducted a pilot study on 
seven patients suffering from resistant chronic oral pemphigus vulgaris (PV). All 
patients reported improvement in pain scores, ability to eat, and healing score [60].
In orthodontic therapy, significant improvement was reported following the 
introduction of local submucosal PRP injection in the pressure side. A single injec-
tion of PRP was enough during active orthodontic treatment (just 2 injections; pre 
and after 6 months). Acceleration of orthodontic tooth movement was reported 
1.7-fold when compared to the conventional traction technique [61] (Figure 8).
4.5 Hyaluronic acid
Black triangles or insufficient interdental papillae are considered a serious 
esthetic problem especially in patients with high lip line [62, 63].
Hyaluronic acid is an important component of the extracellular matrix, 
which has great role in maintaining the health of the oral tissues and healing and 
repair process. The mechanism of its action depends mainly on stimulating the 
cellular proliferation, migration, and vasculature and restoring the integrity of 
epidermal and dermal layer. It is also effective in stimulating collagen formation 
through enhancing the proliferation of fibroblasts. In dentistry, it is recently used 
Figure 6. 
Pre- and postoperative local vitamin C injection in physiologic gingival hyperpigmentation [29].
Figure 7. 
Pre- and postoperative local vitamin C injection in gingival inflammation [45].
77
Oral Mesotherapy: Might Be Considered as An Adjunctive Technique for the Different Surgical…
DOI: http://dx.doi.org/10.5772/intechopen.88355
to accelerate the healing of oral ulcers [64], extraction socket [65], and gingival 
inflammation [66] either through injection or topical application. It was also used in 
reconstruction of the interdental papilla as a minimally invasive technique instead 
of the conventional surgical intervention [67, 68].
4.6 Parathyroid hormone injection
Parathyroid hormone is one of the essential hormones that affect the bone 
metabolism. It was found that its local injection provides acceleration of the orth-
odontic tooth movement 1.6 times faster than the normal movement range. A daily 
local injection of parathyroid hormone (PTH) was also used to induce local bone 
resorption by reducing the concentration of the gel medium using saline [69, 70].
4.7 Relaxin hormone injection
Relaxin is a specialized hormone which was detected in the periodontal liga-
ment providing proper remodeling of the soft tissue rather than the alveolar bone 
surrounding teeth. It provides the needed balance of the collagen content in the 
pressure and tension sites especially during application of forces as orthodontic 
treatment. It was found that the local injection of relaxin could provide an accel-
erated tooth movement by reducing the organization of the related periodontal 
ligaments and increasing the tooth mobility. A weekly injection of 50 μg of relaxin 
hormone was also found to accelerate tooth movement via soft tissue remodeling, 
rather than bone, through increasing the collagen at the tension side over its amount 
in the compression side. It also decreases the organization of the periodontal liga-
ments surrounding the tooth causing extra mobility [70–72].
4.8 Prostaglandin injection
Prostaglandin is one of the most important inflammatory mediators that is usu-
ally secreted during the inflammatory process. It is also considered as a paracrine 
hormone which affects mainly bone resorption level around the teeth by affecting 
the osteoclastic activity. It was found that its local application provides 1.6-fold of 
accelerated tooth movement than the normal range. Formerly, exogenous single or 
multiple prostaglandin injections were used [70, 73, 74].
4.9 Simvastatin
Simvastatin is a chemical agent that is usually used to reduce the serum cholesterol 
level. It was found that it has a positive, stimulatory effect to the bone by stimulation 
Figure 8. 
Submucosal injection of PRP during orthodontic treatment [61].
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of bone growth factors (e.g., BMP-2). On local injection, it was found that simvastatin 
could efficiently treat the infrabony defects and furcation defects and be used for guided 
bone regeneration. The injection visits could range from one to three times with 0.5–2 ml 
per visit. It is considered a successful nonsurgical treatment approach [75] (Figure 9).
4.10 Bone morphogenic proteins (BMPs)
In orthopedics, recombinant BMPs were commonly used during distraction of 
long bones in order to accelerate osteogenic potentials, increase bone volume (both 
width and height), improve bone density, and reduce relapse possibilities. BMP-2 
was commonly used with or without delivery systems as collagen sponge and 
chitosan hydrogel in sequential injections [75, 76] (Figure 10).
4.11 Combinations
Hyaluronidase is one of the proteolytic enzymes that are providing a physiologic 
limiting factor for intercellular cement substance, hyaluronic acid. It was used in 
the treatment of submucous fibrosis by promoting the lysis of accumulated fibrous 
tissues and relieving the stiffness of tissues by intralesional injection. It provides 
a rapid short-term improvement [29, 78]. In addition, corticosteroids could be 
combined with bisphosphonates in the treatment of central giant cell lesions with 
neither recurrence nor clinical side effects being detected [27].
Steroids are well-known immunosuppressive agents which offer a control of 
the inflammation. Up till now, different types of cortisone were used to undergo 
the needed outcome as triamcinolone and dexamethasone. Despite its potency, it 
was preferred because of its cost-effectiveness. Single-dose injection per week was 
needed till improvement is detected, which may extend to 4 months. Progression 




Oral Mesotherapy: Might Be Considered as An Adjunctive Technique for the Different Surgical…
DOI: http://dx.doi.org/10.5772/intechopen.88355
The usage of hyaluronidase and cortisone injection combination provides 
long-term improvement of the signs and symptoms associated with such diseases, 
bringing sensation, ulceration, and pain [29, 77].
5. Oral mesotherapy injection protocol
According to literature, up till now there is no definite protocol for dermal 
mesotherapy. In the oral cavity, it was more difficult to add specific rules due to the 
presence of multiple geometry, types, and dimensions of tissues as gingiva, buc-
cal mucosa, palate, tongue, etc.; we have tried to establish guidelines for general 
practitioners and beginners.
• Oral mesotherapy technique needs longer time for practice in order to achieve 
better results.
• Only minute quantities of injectable agent ranging between 0.05 and 
0.1 ml/point are permissible according to the range of the injected tissue 
expansion.
• In 1965, Woodard recommended that the pH of any injected material should 
range between 4.5 and 8.0. Local injections show lower rate of buffering 
capacity than intravenous and intramuscular route. During oral mesotherapy 
injection, higher pH is preferred.
Figure 10. 
Bone morphogenic protein injection [75].
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• The used needle has to be short, beveled. The needle’s gauge should range 
between 25 and 30.
• Numerous sites for administration of different injectable products are still accept-
able till now. The buccal mucosa, buccal vestibule, palate, labial gingival tissues, 
interdental papilla, and tongue are the most common sites for local injections.
• On the contrary to the skin, oral mucosa is always wet. Surface cleaning and 
dryness using dry gauze is recommended without the usage of surface disin-
fectant. Local anesthetic or analgesic agent (specific for intraoral usage) is also 
recommended accompanying the usage of specific agents as vitamin C due to 
its nature as a weak acid. In general, the usage of any injectable agent causes 
local inflammation and induces pain and itching.
• Preoperative treatment plan and patient preparation are the most important 
steps in the whole treatment procedure. Detailed patient’s medical history is an 
important issue. The target tissue should be free of infection and clean. Two visits 
for periodontal debridement are recommended; the first is preferred to be per-
formed 2 weeks prior to the procedure, while the other is usually performed prior 
to the injection visit especially if the injection will be more related to the teeth. 
The patient should be instructed to keep away from vitamin E and aspirin 1 week 
before the injection session. After the session, the patient must be instructed that 
discomfort or burning could occur for 20 minutes. Analgesics are not permitted.
6. Complications and criticism of mesotherapy
The main complications reported in this technique include ulceration, bleeding, 
infections, allergy, abscess, hyperpigmentation, and swelling related to the area to be 
injected [78, 79]. The main problems of mesotherapy are the lack of training of the 
practitioner, the difficulty to be evaluated except with biopsy, the inability to diag-
nose and treat a complication, and the lack of standardized dosage or formulation [1].
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